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ABSTRACT 
This thesis describes the identification, isolation and partial characterisation of VapA-
encoded virulence plasmids present in Rhodococcus equi (R. equi) found in foals in 
New Zealand. R. equi infection associated with the presence of virulence plasmids 
causes severe pyogranulomatous pneumonia in foals and, if left untreated, it can be 
lethal. Foals are thought to be infected when they ingest or breathe in bacteria present 
in soil, dust and faecal particles after which the bacteria multiply inside macrophages 
and cause pneumonia. Studies have shown that virulence is associated with the 
presence of the vapA gene in a plasmid that encodes a VapA protein. Twelve different 
types of VapA-encoding virulence plasmids have been described so far. 
Epidemiological studies of America, Australia, Korea, Japan and some parts of 
Europe have revealed that more than one subtype can exist in a farm or even a 
country. The aim of the study was to investigate if more than one subtype of VapA-
encoded plasmids exists in a farm in New Zealand. 
                Nasal swabs for the analysis were obtained from the Auckland Veterinary 
Centre in Papakura. Based on colony morphology and 16S primers, successful 
identification of R. equi was possible, VapA primers assisted with distinguishing 
bacteria that carried VapA-encoded plasmids. Since success with plasmid isolations 
was modest, characterization of plasmids was conducted by sequence analysis of an 
approximately 1-kb variable region present in VapA-encoded plasmids. Sequence 
analysis and restriction digestion patterns revealed two distinct patterns of sequences 
from the variable region which were divided into two groups: PI and PII.  
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               Results indicated that PI sequences were significantly similar to published 
85-kb type I plasmids and must also be from 85-kb type I plasmids but more detailed 
analysis of other regions is required to confirm the results. PII sequences on the other 
hand were distinctly different from PI sequences and displayed poor matches with 
published plasmid sequences. This is the first attempt at characterising VapA-
encoded virulence plasmids from R. equi isolates in New Zealand. This work will 
contribute towards increasing our knowledge regarding the unique characteristics of 
the VapA-encoding plasmids, which could define transmission characteristics, 
possible sources of infection in disease outbreaks and vaccine development. 
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PREFACE 
This thesis begins with a Literature Review (Chapter 1), which describes R. equi 
growth, morphology, biochemistry, infection, spread of infection, immunity against 
infection and treatment of infection. A review on R. equi species-specific molecular 
markers, R. equi virulence molecular markers and VapA genetics follows after which 
there is a brief description of the proposed methodology which includes the aims of 
the project and finally a conclusion that highlights the importance of the study.  
Chapter 2 is presented in the form of a research paper prepared for publication in a 
scientific journal. The main findings of this research project are presented here. 
Chapter 3 provides a conclusion, including a summary of results and some 
suggestions and recommendations for further research. The references are found in 
Chapter 4. Chapter 5, which is the Appendix section, includes additional protocols, 
recipes of solutions and results that are not presented in Chapter 2, including DNA 
extractions, PCR optimisation and post-PCR processing of DNA. The appendices 
also contain additional gel photos of all strains of R. equi tested with 16S, VapA and 
TraA primers. The appendices section concludes with a BLAST analysis of all PI and 
PII isolates of R. equi and electropherograms of a PI and PII isolate. The alignment of 
the four published plasmid sequences, table of ORFs in virulence plasmid p33701, 
amplification regions of primer 74 and 76 and the electropherogram data for all 21 PI 
and PII sequences can be found on the CD at the back of the thesis. Also, the area 
selected for amplification is highlighted in the plasmid alignments and the links to 
software required to view the electropherograms are available.  
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1 Literature Review 
1.1 Introduction 
 Members of the Rhodococcus genus which was first described by Zopf in 1891 are 
gram-positive, aerobic, non-motile, non-sporulating (Singer & Finnerty 1988) and 
metabolically diverse bacteria (Larkin et al. 2005). The genus Rhodococcus („red 
pigmented cocci‟) belongs to the phylogenetic group described as nocardioform 
actinomycetes, on the basis of cell wall composition (Tkachuksaad & Prescott 1991; 
Finnerty 1992). The order being Actinomycetales, the suborder is Corynebacterineae 
and the family is Nocardiaceae (Magnusson 1923; Goodfellow & Alderson 1977). 
They can be found in various environments including plant surfaces, soils, insect 
guts, ground water, boreholes, marine sediments, rocks, animal faeces etc 
(Goodfellow 1989; Bell et al. 1998). Warhurst and Fewson (1994) have commented 
that Rhodococci can persist in soil even under starvation conditions thus emphasising 
their robustness. Virulent Rhodococcus have been isolated in countries such as 
Australia, Japan, Korea, America and in parts of Europe. Since the Rhodococcus cell 
wall consists of aliphatic chains of mycolic acids, thus making the cell hydrophobic, 
they may be able to degrade hydrophobic pollutants by allowing cells to adhere 
oil/water interphases (Bell et al. 1998). The Rhodococcus species include symbionts 
like R. rhodnii and other members like R. globerulus, R. erythropolis, R. rhodochrous 
which are known for their ability to degrade hazardous chemicals such as 
polychlorinated biphenyls (Bell et al. 1998) R. percolatus, R. erythropolis and R. 
rubber are known to produce surfactants which contain both strongly hydrophobic 
and hydrophilic groups and are thus able to migrate to interphases between oil and 
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aqueous phases, this allows the inexpensive purification of biosurfactants that in turn 
is used for biodegradation of pollutants (Bell et al. 1998). Rhodococcus (R. equi) - 
previously called Corynebacterium equi -was first described by Magnusson in 1923 
based on an isolate from the lung of an infected foal (Takai 1997). The bacteria are 
surrounded by a complex thick and lamellar polysaccharide capsule (von Bargen & 
Haas 2009) that contains mycolic acid side chains (Hondalus 1994).  R. equi strains 
are pathogenic (Anzai et al. 1997), affect foals less than four months of age 
(Tkachuksaad & Prescott 1991), have a circular chromosome that is c. 5 Mb (Sanger 
2008) and can have different types of plasmids some of which are found to be linked 
with virulence (von Bargen & Haas 2009). The R. equi genome is 5,043,170 bp in 
length and has a G+C content of approximately 68.82%.  Shotgun sequencing data 
reveals that there are 91,118 reads totalling 43.169 Mb and giving a theoretical 
coverage of 99.97% of the genome (Sanger 2008).  
1.1.1 Media, Morphology and Biochemistry 
A selective medium that prevented the growth of many competing organisms was 
developed; it consisted of a trypticase soy agar (TSA) base to which nalidixic acid 
(20 µg/ml), novobiocin (25 µg/ml), actidione (Cyclohexamide) (40 µg/ml) and 
potassium tellurite (0.005%) (Woolcock et al. 1979). This medium was named 
NANAT and has been used for R. equi selective growth for the past 30 years 
(Muscatello 2006).  However, the base medium TSA and the modifications made to it 
produced unsatisfactory colony morphology and “did not allow” differentiation of 
bacteria, thus blood agar was substituted as the base medium (Woolcock et al. 1979). 
Comparisons of NANAT with other media such as CAZ-NB {Mueller-Hinton agar 
3 
 
base with the addition of ceftazidime (20 µg/ml) and novobiocin (25 µg/ml)} for R. 
equi recovery have been made but none are found to be significantly more effective 
than NANAT (Woolcock et al. 1979; Muscatello 2006). Although sheep blood agar 
has been recommended, many recent studies have successfully used Blood Heart 
Infusion (BHI) agar as the base medium and this is also the media chosen for use in 
this study. The addition of polymyxin B (30 µg/ml) to the NANAT medium has been 
suggested to resolve the problem of P.aeruginosa growth (Woolcock et al. 1979) and 
is also incorporated in the NANAT medium used for this study. 
          Depending on the growth conditions, R. equi morphology varies, after 4 h 
(hours) of growth in culture broth bacteria are rod shaped but become coccoid after a 
day of growth in liquid media or on blood agar (von Bargen & Haas 2009), viscous-
mucoid coalescing colonies are predominant in fresh cultures (Prescott 1991). After 
24 h, colonies are 1 to 2 mm in diameter but by 48 h they develop their characteristic 
appearance: irregularly round, smooth, mucoid, glistening, semitransparent, salmon 
pink to yellow coloured and coalescing colonies (Prescott 1991). They are not known 
to have flagellae but some strains have pili or appendages (von Bargen & Haas 2009). 
The optimal growth temperature for R. equi growth is between 30 and 37ºC and 
colonies develop into a shade of salmon pink to yellow after a few days of growth on 
(Prescott 1991).  
             Species within the Rhodococcus genus have an oxidative metabolism and are 
categorized by their capability to utilize unusual compounds such as alicyclics, 
polycyclic hydrocarbons, steroids and nitroaromatic compounds 
(DeLaPenaMoctezuma et al. 1996). The organism is biochemically un-reactive as it is 
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unable to oxidize or ferment any alcohols or carbohydrates (Prescott et al. 1991). 
Their nutritional requirements are simple; they can utilize carbon from many different 
sources and simple organic acids such as acetate, which can be obtained from 
herbivore manure (von Bargen & Haas 2009), as well as a variety of sugars 
(DeLaPenaMoctezuma et al. 1996). Nitrogen can be utilized from ammonium 
sulphate or potassium nitrate (Prescott 1991). R.equi produces equi factors that are 
known to interact with the beta-toxin of S. aureus, phospholipase D of 
Corynebacterium psuedotuberculosis and a partial hemolysin of L. monocytogenes 
thereby giving an area of complete hemolysis with cattle erythrocytes (Prescott et al. 
1982). Although this characteristic is not unique to R. equi, no negative isolates of R. 
equi display this property, so it is useful for R. equi identification (Prescott et al. 
1982).   
1.1.2 R. equi Infection in Foals and other Species 
For over 80 years R. equi has been recognized as a pulmonary pathogen of horses. It 
is known for zoonotic infections in foals that are between 1 and 4 months of age 
(Tkachuksaad & Prescott 1991; Yager et al. 1991; von Bargen & Haas 2009). It has 
been ranked as among the four most important disease problems in the horse industry 
especially because of its high prevalence and mortality rate, which is approximately 
28% (Blood-Horse 2009; Muscatello 2009). Symptoms in foals include fever and 
respiratory distress; pulmonary lesions and chronic pus-filled lung abscesses, which 
develop in early stages of the disease and if left untreated can cause death by 
asphyxiation (Wichtel et al. 1991; Lavoie et al. 1994). Clinical signs include 
coughing, thick greenish-white nasal discharge, lethargy and an increased respiratory 
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rate (Blood-Horse 2009). The infection can spread from the lungs to other organs and 
joints when granulomatous foci in the lung open up (Prescott 1991). Infection of the 
gut lining causes diarrhoea with an ulcerative enteritis and mucosal invasion of R. 
equi which is frequently observed in chronic disease (Bell et al. 1998; Vazquez-
Boland et al. 2009). Immune complex deposition in synovial membranes can cause 
polysynovitis which contribute to the development of uveitis, anemia or 
thrombocytopenia in infected foals (Giguere et al. 1999). Occasionally, osteomyelitis 
and arthritis are also observed (Giguere et al. 1999). Although infections can 
sometimes occur in healthy adult horses they are more common and severe in foals 
due to their compromised immunity (Hondalus 1994). However,  both adult horses 
and some foals are able to develop protective immunity and quickly clear infection 
when re-exposed to virulent R. equi (Lopez et al. 2002). It has been found that only a 
small proportion of all R. equi in soil are able to cause the infection and only R. equi 
carrying virulence plasmids can cause disease in foals (Muscatello et al. 2006b). Foal 
to foal transmission of R. equi has not yet been documented (von Bargen & Haas 
2009) but exhaled air from foals may be a significant source of virulent R. equi for 
other foals (Muscatello 2006). In some strains of R. equi, presence of a plasmid (as 
shown in Figure 1.1 below) encoding a 15-17kDa protein called VapA (Virulence 
Associated Protein A) is known to be responsible for virulence (Takai 1991b; 
Tkachuksaad & Prescott 1991).  
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Figure 1.1: Map of the R. equi virulence plasmid p33701. The circle shows 
orientation of the ORFs, with the direction of reading denoted by shading. Genes with 
a known or suspected putative function based on homology with genes of a known 
function in DNA databases are named (Takai et al. 2000).  
                      R. equi infect immunocompromised hosts by multiplying within 
macrophages, seizing the normal pathway of phagosome maturation and this 
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eventually results in necrotic death of the infected cell (Hondalus 1994; Luhrmann et 
al. 2004). This causes severe pyogranulomatous pneumonia in foals which is 
characterized by inflammation and lung abscesses and, if left untreated, can be fatal 
(Takai et al. 1993). This disease (commonly called “rattles”) is estimated to affect up 
to 17% of foals worldwide (Elissalde et al. 1980). In Australia 1-10% of foals are 
affected, although antibiotic treatment reduces mortality rates to less than 1%; yet, in 
some farms mortality rates are as high as 20% or greater (Muscatello et al. 2006b). 
As shown in Figure 1.2 which shows the distribution of VapA among species, in 85% 
of cases the presence of a VapA encoding virulence plasmid has been associated with 
R. equi infection in foals for the last couple of decades (Rodriguez-Lazaro et al. 
2006). Experiments with the presence of the VapA-expressing plasmid in R. equi 
showed an increase in the percentage of killed macrophages in a standard assay using 
trypan blue by roughly 20 to 70% in comparison with its cured equivalent strain 
(Luhrmann et al. 2004). 
                 R. equi infrequently infects other animals such as pigs, goats and cattle but 
is increasingly responsible for AIDS-associated pneumonia in HIV-infected 
individuals (Meijer & Prescott 2004; Wall et al. 2005). Infections in bovine and pig 
isolates have been associated with the presence of VapB-encoding plasmids 
(Ocampo-Sosa et al. 2007). Infections are also observed in patients with organ 
transplants, renal failure, alcoholism, lung cancer, leukaemia and other conditions 
related to immunodeficiency (Kedlaya et al. 2001). Human infections with R. equi are 
uncommon, affecting approximately 10-15% of immunocompetent patients (Gabriels 
et al. 2006). The best therapeutic approach is a two-step strategy; in the first step a 
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combination of bactericidal drugs such as vancomycin plus imipenem is used to kill 
extracellular organisms and, in the second step, a combination of drugs that penetrate 
the cell, such as erythromycin plus rifampicin, are administered for a period of at 
least two months (Gabriels et al. 2006). The pathogen in plants is known as R. 
fascians (von Bargen & Haas 2009). The infection causes growth abnormalities such 
as loss of apical dominance and the growth of lateral shoots, evidence suggests that 
the abnormalities are caused by the production of cytokines by R. fascians (Bell et al. 
1998). Plasmids in Rhodococcus species other than R. equi have been linked to 
resistance to heavy metals and to chloramphenicol, disease processes in plants and the 
metabolism of extraordinary compounds (DeLaPenaMoctezuma et al. 1996). R. 
fascians infections in crops on farms can lead to large economic losses. 
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Figure 1.2: Distribution of the vapA allele according to isolate origin. The number of 
isolates within each category is indicated above the bars; within the bars are the 
percentages of vapA
+ 
(shaded region) and vapA
-
 (blank region).  (Rodriguez-Lazaro et 
al. 2006) 
1.1.3 Spread of R. equi Infection in foals 
 Foals with clinical disease have been found to have considerably high concentrations 
of R. equi in their faeces, thus faeces from foals is thought to be the main source of 
soil contamination (Takai 1991a; Takai et al. 1994; Takai 1995; Muscatello et al. 
2006a). R. equi multiplies exceptionally well during temperate spring and summer 
conditions in soil that in contaminated with the manure (Muscatello et al. 2006a). It 
has been observed that as the concentration of virulent organisms in the 
environmental R. equi population increase there is an increased risk of inhalation of 
R. equi from the soil (Takai 1997).  Minimising the time foals spend in laneways and 
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holding pens where areas are covered with dry and acidic soils can help reduce their 
exposure to R. equi (Muscatello et al. 2006a).  Environmental conditions favourable 
for R. equi multiplication in the soil and aerosolization of R. equi from the soil are 
considered high risk for foals (Muscatello 2009). Due to the problematic recovery of 
R. equi from tracheal lavage fluid samples with clinical R. equi pneumonia, the 
intracellular habitat of R. equi in the alveolar macrophages of infected foals and the 
production of abscesses in the lungs of infected foals, it is suggested that direct foal to 
foal transmission is unlikely (Martens et al. 1982; Barton & Embury 1987).  
Although the sensitivity of air sampling techniques is similar to tracheal lavage fluid 
samples, the specificity of the test is poor since most of the healthy foals‟ also exhale 
virulent R. equi thus proving that attempting to diagnose R. equi pneumonia is 
difficult, as healthy foals could also be a source of infection (Muscatello et al. 2006a) 
1.1.4 Immunity against R. equi infections in Foals 
There is evidence to supporting the idea that susceptibility to infection is determined 
by differences in immune functions in foals (Nerren et al. 2009b). A study by 
(Chaffin et al. 2003) has confirmed that the ratio of CD4+/CD8+ T cells in blood 
samples from 2-week-old foals was considerably lower in foals that later developed 
R. equi pneumonia than in foals that did not develop the disease. Protection against R. 
equi infection is provided by CD4+ and CD8+ lymphocytes, therefore clearance of 
virulent R. equi in mature horses is dependent on interferon gamma production by 
CD4+ and CD8+ lymphocytes (Nerren et al. 2009a) R. equi infection in adult horses 
is also known to be cleared by R. equi-specific cytotoxic T lymphocyte responses 
(Nerren et al. 2009b). Pulmonary clearance of R. equi is shown to be enhanced by 
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antibodies of the Vap proteins but these do not provide complete protection (Jacks et 
al. 2007). Although the mechanism is unclear, there is evidence that neutrophils play 
an important role in resistance to infection with R. equi and may also have a 
protective effect by forming a link between adaptive and immune responses (Nerren 
et al. 2009a). Neutrophils produce a number of cytokines and chemokines that 
activate other effector cells of the immune system thereby initiating an immune 
response (Nerren et al. 2009a). Analysis of the expression of 8 cytokines (IFNy, 
TFNα, IL-6, IL-8, IL-12p40, ILP-12p35 and IL-23p19) in response to R. equi 
infection from newborn foals and subsequently at 2-, 4- and 8 weeks of age revealed 
that on exposure to virulent R. equi, expression of these cytokines would increase 
with age (Nerren et al. 2009b). The R. equi specificity of the above responses was 
unable to be examined since other bacterial species were not included in the 
experiment (Nerren et al. 2009b). Furthermore, a generalized IFN-γ deficiency or 
inapt polarization of the immune response towards the Th2 phenotype cannot alone 
explain susceptibility to R. equi infection (Jacks et al. 2007). However, understanding 
the mechanism of innate and adaptive immunity and the reasons why some foals are 
more susceptible to R. equi infection than others will provide helpful information for 
vaccine development. 
 
1.1.5 Treatment of R. equi infection  
            R. equi is usually resistant to beta-lactam antibiotics such as penicillin G, 
oxacillin, ampicillin, carbeicillin and cefazolin (Kedlaya et al. 2001). Current 
treatment involves the usage of a combination of erythromycin estolate and rifampin 
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(Jacks 2003). Before the advent of the above combined antimicrobial therapy, fatality 
rates were as high as 80% but studies conducted around 2006 showed that these rates 
could be reduced to between 12.5 and 42% after administration of the antibiotic 
cocktail (Heidmann et al. 2006). This combination allows the drugs to penetrate the 
lung abscesses, macrophages or neutrophils where the bacteria multiply (Prescott 
1991). Normally treatment of 30 days is prescribed but prolonged treatment of 6-8 
weeks can often be required. Radiographs and fibrinogen levels are used to determine 
when to stop treatment (Prescott 1991).  However, the side-effects of antibiotic usage 
include hyperthermia, fatal diarrhoea and are normally self-limiting. Erythromycin 
has variable absorption and is associated with effects such as colitis and tachypnea in 
hot weather (Heidmann et al. 2006). In the last decade the minimal inhibitory 
concentrations of erythromycin and rifampin for R. equi isolates have been rising and 
there have been reports of strains becoming resistant to these antibiotics (von Bargen 
& Haas 2009). In one study, prophylaxis with azithromycin tested on foals for a 
period of 28 days proved to be insufficient for reducing the incidence of pulmonary 
abscesses (Venner 2007). This highlights the need for non-antibiotic strategies to 
combat R.equi infection. Other methods for treatment rely on reducing faecal 
contamination and dust on studs but the effects of such methods have been variable 
and little is known about how much these factors account for higher rates of mortality 
and infection on some studs (Muscatello 2006). Another monitoring tool in farms 
with endemic R. equi infection is the periodic analysis of white blood cell 
concentrations (von Bargen & Haas 2009), the cultivation of bacteria from tracheal 
washes and identifying R. equi by PCR (as carried out in this study) is also 
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recommended (Heidmann et al. 2006). Another study also implies that laneways and 
holding pens are major infection areas, if the time spent by the foals in these 
environments is reduced and if these areas were regularly irrigated then there may be 
a decline in airborne concentration of virulent R. equi (Muscatello et al. 2006a). 
              The only useful precautionary medical strategy against R.equi is the 
intravenous administration of hyperimmune plasma (HIP) (Blood-Horse 2009). This 
contains high levels of antibodies against the bacteria. HIP can provide passive 
immunity to treated foals and also reduces the incidence of pneumonia (Blood-Horse 
2009). Nonetheless, it is expensive, labour intensive to administer and not universally 
effective (Blood-Horse 2009). Despite these limitations, HIP is commercially 
available and still being used on many farms (von Bargen & Haas 2009). There is 
currently no effective vaccine or a rapid, inexpensive method of early diagnosis and 
prevention of R. equi infection in foals (Rodriguez-Lazaro et al. 2006). Many 
attempts for vaccine developments have been made over the years but none have 
proven to be very successful. The development of a GroEL/VapA epitope chimeric 
(combination) protein/DNA vaccine was possible however there is still a need for a 
non-equine model of R. equi infection (Heuzenroeder et al. 2005). 
 
1.1.6 Research on R. equi Virulence Determinants 
            R. equi grown on acetate- or lactate-containing minimal media revealed its 
high activities of isocitrate lyase (Kelly et al. 2002). Isocitrate lyase is the first 
enzyme of the glyoxylate bypass, which allows assimilation of acetate via the 
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glyoxylate bypass (Wall et al. 2005). Isocitrate lyase is encoded by the aceA gene, 
thus by constructing an aceA mutant of strain R. equi 103 (R. equi lacking isocitrate 
lyase activity) (Wall et al. 2005) were able to understand the role of isocitrate lyase in 
virulence of R. equi. On the surface of R. equi, a Haemagglutinin has been described 
as a potential virulence marker of this species (Soedarmanto et al. 1998). A 
relationship between haemaglutinin‟s adherence of this bacteria to HeLa cells (an 
immortal carcinoma cell line) or to murine macrophages has been found 
(Soedarmanto et al. 1998). 
              Bacterial capsules have been shown to adhere to biotic and abiotic surfaces, 
are resistant to complement-mediated killing, suppress adapted immune responses 
and are resistant to desiccation (Sydor et al. 2008). In a study, the authors created a 
transposome mutation in the gene for mycolyl transferase FbpA which resulted in the 
apparent loss of capsule structure in R. equi (Sydor et al. 2008). These mutants with 
disturbed capsule structures were shown to release factors for virulence more 
successfully and therefore had stronger virulence characteristics (Sydor et al. 2008). 
Since the mutation inflicted by the transposome affected capsule adhesion, mycolic 
acid compound synthesis and possibly other phenotypes it was difficult to understand 
the role of each of these effects (Sydor et al. 2008). However the role of the capsule 
in virulence remains negligible due to the fact that the overall role of virulence in 
mice was unaltered (Sydor et al. 2008). Although the capsule showed little relevance 
to virulence it might be crucial for R. equi survival in dry soil (von Bargen & Haas 
2009). HeLa cell association with the presence of virulence plasmids in R. equi was 
examined in eight R. equi isolates but no relationship between them was found (De la 
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Pena-Moctezuma & Prescott 1995). A determinant that influenced the association 
was the colony type, the dry colonies showed a higher HeLa cell-presence of plasmid 
association possibly because they are more hydrophobic (play a role in permitting 
adhesion) than the mucoid colonies; however there was no relation between 
hydrophobicity and possession of the VapA plasmid (De la Pena-Moctezuma & 
Prescott 1995).  The HeLa cell was not a useful model in assessment of virulence 
plasmids thus suggesting that macrophages may be a better cell model for in vitro 
assessment of virulence. Pei et al. (2006) examined the application of a system they 
developed to target gene mutations and to assess their importance in resistance to 
immune defences. Mutations in a gene htrA (a stress-induced serine protease) 
required for maturation and folding of secreted proteins which is known to be 
involved in virulence of many gram negative bacteria has shown to be required for R. 
equi virulence (Pei et al. 2006). The gene narG (encodes nitrate reductase G) in the 
absence of oxygen is known to play a role in respiration, the indication of its 
requirement for virulence in R. equi was observed when the narG mutant of R. equi in 
mice was fully attenuated (Pei et al. 2006).  The limitation of this study is that using 
healthy adult mice to assess virulence of mutant strains will fail to show attenuation 
that might only be observed in activated macrophages (Pei et al. 2006). It seemed that 
in pathogenic bacteria there are examples of virulence factors that act cooperatively 
to cause membrane damage (Navas et al. 2001). 
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1.2 Species-Specific Molecular Markers of R. equi 
1.2.1 16S Ribosomal RNA  
16S rRNA sequencing has been generally accepted as a means for species 
differentiation. The gene sequence for 16S rRNA is largely phylogenetically 
conserved therefore variable regions in its sequence can be characteristic of particular 
organisms (Bell et al. 1996).  Comparative analysis of 16S rRNA sequences can be 
carried out with universal PCR primers due to the presence of highly conserved 
primer binding sites and hypervariable regions that provide species specific 
signatures (Coenye & Vandamme 2003). The primers allow amplification of a 441-bp 
segment of DNA from all R. equi strain (Sellon et al. 2001) and have been used in 
this study and others to confirm that the visually identified isolates belong to R. equi.  
1.2.2 Colony Hybridisation using an rrnA probe  
In a study by Muscatello and Browning (2004), a rrnA probe was used to hybridize to 
and identify R. equi colonies; however, of the 14 colonies that hybridized to the rrnA 
probe, six of them had colony morphology atypical of R. equi. On increasing the 
hybridization temperature and the stringency of the wash buffer, the binding of the 
rrnA probe to these atypical R. equi isolates was eliminated, leaving genuine positive 
colonies (Muscatello & Browning 2004). Thus specific identification of R. equi 
colonies was possible using the rrnA probe.            
1.2.3 Cholesterol oxidase gene (choE) gene 
Studies have suggested a high degree of conservation of the choE gene in R. equi 
(Ladron et al. 2003). DNA sequencing and Restriction Fragment Length 
17 
 
Polymorphism (RFLP) analysis have confirmed the above suggestion i.e. RFLP 
analyses of the 959-bp choE amplicons from 20 previously analyzed R. equi isolates 
showed identical patterns for each of the seven restriction enzymes that were used 
(Ladron et al. 2003). Thus choE was a good target for species specific identification 
of the nocardioform actinomycete, R. equi. In another study, a molecular analysis of 
R. equi virulence was conducted by investigating cholesterol oxidase using choE 
mutants (Navas et al. 2001). Inactivation of choE annulled the rhodococcal 
cohemolytic activity but was restored on complementation of choE (Navas et al. 
2001). The expression of choE in a strain of E. coli conferred the same membrane 
damaging activity as in the wild-type strain of R. equi (Navas et al. 2001). This 
supports the current belief that cholesterol oxidase is a major cytotoxic factor that is 
possibly involved in the macrophage and leukocyte destruction that characterizes 
infections in humans and animals (Prescott 1991; Linder & Bernheimer 1997). There 
is evidence that R. equi also produces phospholipase activity that, together with choE, 
forms a system that efficiently alters host membranes and causes cytotoxicity and 
tissue destruction (Linder & Bernheimer 1997; Navas et al. 2001). 
 
1.3 Molecular Markers of Virulence in R. equi  
1.3.1 VapA 
A number of studies have shown that the possession of a vapA gene encoding VapA 
protein has been associated with virulence in R. equi (Takai 1991b, a; Tkachuksaad & 
Prescott 1991; Takai et al. 1993). Although many phenotypic markers such as congo 
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red binding, resistance to antibiotics, conventional clinical microbiological tests, 
utilization of different carbon sources have been tested as methods for detection of 
virulence, VapA seems to be a more reliable indicator of virulence 
(DeLaPenaMoctezuma et al. 1996). A plasmid–typing scheme described by 
(Ocampo-Sosa et al. 2007) suggests that the presence or absence of the plasmid genes 
traA (959-bp)[A conserved gene for plasmid transfer shown to be functional in other 
Rhodococcus species (Yang et al. 2007)] and the genes vapA (286-bp) and vapB 
(477-bp) determine virulence in Rhodococcus species. Strains that have the 
characteristic traA
+
 vapA
+
 vapB
-
 are found in isolates from sick foals, traA
+
 vapA
- 
vapB
+
 prevail in those from predominantly asymptomatic pigs, the traA
+ 
vapAB
- 
is 
characteristic of virulence plasmids frequently found in diseased cattle and traA
-
 
vapAB
- 
(no plasmid) is typical nonpathological isolates (Ocampo-Sosa et al. 2007; 
von Bargen & Haas 2009). The distribution of the above mentioned TRAVAP 
categories is shown below in Figure 1.3. Thus the presence or absence of the vapA 
gene can be used as a marker to show presence or absence of the VapA-encoding 
virulence plasmid. Virulence plasmid negative strains of R. equi do not express vapA 
and are therefore incapable of causing disease (Jain 2003). 
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Figure 1.3: Distribution of the 4 traA‐vapA‐vapB (TRAVAP) categories as a 
function of the origin of the R. equi isolates. The no. of isolates within each group is 
indicated above the bars, and the percentages of the different plasmid categories are 
indicated inside the bars (Ocampo-Sosa et al. 2007). 
          When the vapA gene was expressed in a plasmid-cured isogenic strain of R. 
equi it was not sufficient enough to restore the capacity to proliferate in macrophages 
and to colonize the lungs of experimentally infected foals (Navas et al. 2001). Thus 
the role of vapA in virulence has been questioned. Since the involvement of vapA and 
the presence of the virulence plasmid alone do not appear to be essential in 
pathogenesis in non-horse hosts, such as clinical isolates from humans and other 
animal species, it has been suggested that chromosomally determined factors are 
involved in R. equi pathogenicity (Navas et al. 2001). Candidates for such 
chromosomal virulence factors include; the capsular polysaccharide (which might 
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interfere with phagocytosis), mycolic acid-containing glycolipids (which might be 
involved in granuloma formation), cholesterol oxidase (an enzyme that might be 
involved in cytoxicity and macrophage destruction) (Navas et al. 2001). However, 
there is no direct proof of any of the above factors involvement in pathogenesis 
(Navas et al. 2001). VapA is a greatly immunodominant protein and is abundantly 
expressed on the bacterial surface (Takai et al. 2001). It is thought that VapA is 
linked to the cell wall through an abnormal lipid modification that occurs at the N-
terminal end so that at least the conserved C terminal region of VapA is presented on 
the surface of the organism (Tan et al. 1995; Takai et al. 2001).  
1.3.2 VapB 
VapB is identified in plasmids from „nonequine‟ R. equi isolates (Lazaro et al., 
2006). A 20 kDa virulence protein seems to be related to 79 to 95 kb plasmids that 
are generally found among R. equi isolates from pigs and HIV infected persons 
(Soedarmanto et al. 1998). These 20 kDa proteins are suggested to represent 
intermediately virulent R. equi (Soedarmanto et al. 1998) and in order for them to 
impose lethality in mice there needs to be bacterial numbers 10 times higher than for 
VapA-expressing strains (Takai 1995; Takai et al. 2000). VapA and VapB sequences 
are strongly related to each other and have a sequence identity of 83.6% (von Bargen 
& Haas 2009), clinical isolates can express VapA or VapB but not both (Monego et 
al. 2009). The VapB-encoding plasmid codes for 4 proteins along with VapB which 
are different to those found in VapA they are: VapJ, VapL, VapM and two copies of 
VapK (Letek et al. 2008).  
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1.4 VapA Genetics 
1.4.1 VapA Regulation and Expression 
VapA expression is thermoregulated and pH regulated, occurring at temperatures 
greater than 32ºC and at a pH of 5.0 (Takai 1991b, 1999; Benoit et al. 2001, 2002). 
Studies have shown that increased temperatures have the strongest impact on 
induction of VapA expression (Ren 2004). Broth composition has also shown to be 
involved in regulating the expression of VapA: when additional amounts of yeast 
extract is added to brain heart infusion broth (BHI) VapA is synthesised even at 30ºC 
(Byrne et al. 2007). Oxidative stress and the concentration of calcium and magnesium 
also control expression of VapA gene and other genes in the pathogenicity island 
(Wall et al. 2005) 
           Two genes encoding transcriptional regulators are located in a five-cistron 
operon (the virR operon) and are found to play an important role in controlling the 
expression of pathogenicity island genes (Byrne et al. 2007).  The virR operon 
contains ORF4 and ORF8 genes that are found on virulence plasmids and are 
involved in regulation of VapA (Russell et al. 2004). ORF4 codes for a LysR-type 
transcription regulator (VirR), and ORF8 is homologous to response regulators of 
two-component regulatory systems (VirS), both are identified in the pathogenicity 
island (Takai et al. 2000; Russell et al. 2004). When virR or virS were knocked out an 
upregulation of mRNA levels of all vap genes, including vapA, was observed (Ren 
2004). This led to the assumption that regulation of genes encoded in the 
pathogenicity island is mainly based on a negative transcription regulatory network 
(Ren 2004). Even while vapA mRNA increased when virS was deleted, VapA protein 
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was not expressed and the explanation for this remained to be investigated (Russell et 
al. 2004). Although virR  is transcribed at a constitutive low level its transcription is 
driven by the PvirR promoter  which has a start site 53 bp upstream of the virR 
initiation codon (Byrne et al. 2007) .  Deletion analysis of the virR operon revealed 
that transcription of the 4 genes downstream of virR is driven by a second promoter 
(Porf5) which is also located within the virR gene (Byrne et al. 2007).  Investigation of 
virulence plasmid-free R. equi strains showed that the activity of Porf5 was 
significantly reduced than that in the presence of the virulence plasmid, suggesting 
that for full Porf5 activity one or more components of the virulence plasmid was 
required including the virR gene (Byrne et al. 2007).  Although the role of Orf5 is 
unclear, inducing growth conditions to upregulate Porf5 activity will result in the 
increased expression of the response regulator Orf8 which would in turn lead to full 
induction of the virulence genes (Byrne et al. 2007). 
1.4.2 VapA-encoding Plasmids 
                 Plasmids encoding VapA that are around 85-90 kb have been analysed 
intensely due to their central role in virulence in foals (Jain 2003). These plasmids 
belong to the CURV (conjugation-unknown function-replication/partition-variable 
region) family of plasmids, the variable region contains the „pathogenicity islands‟ 
and hence is a region of interest (von Bargen & Haas 2009). A distinct feature of the 
CURV plasmid family is the presence of a highly conserved syntenic gene cluster 
which includes conserved conjugal transfer genes and spans part of the conjugation 
and unknown-function modules (Letek et al. 2008). A family of four other vap genes 
(vapC, vapD, vapE and vapF) that comprise the pathogenicity island are also known 
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to be involved in virulence with the exception of two other individual genes vapG and 
vapH (Jain 2003). Proteins encoded by vap genes exhibit significant sequence 
conservation and no proteins homologous to the Vap are found in other organisms 
(Jain 2003). The plasmid is essential for multiplication in macrophages and by 
enhancing cytotoxicity is able to allow prolonged inhibition of phagosome maturation 
(Hondalus 1994; Giguere et al. 1999; Luhrmann et al. 2004). Twelve different (85-kb 
types I to IV, 87-kb types I to III, and 90-kb types I to V) but remarkably conserved 
VapA-encoding plasmids have been described based on their endonuclease restriction 
patterns and some seem to be accumulated geographically (Takai et al. 2001; Takai et 
al. 2003; Ribeiro 2005; Venner et al. 2007). A second type of plasmid, the VapB-
expressing plasmid contains the VapB gene which is structurally homologous to the 
VapA gene, this VapB plasmid has been isolated from pigs and AIDS (Acquired 
Immune Deficiency Syndrome) infected patients (Luhrmann et al. 2004). Along with 
some evolutionary reasons for the presence of different forms of the virulence-
associated proteins which is documented further below, the involvement of lipid 
modifications has been suggested (von Bargen & Haas 2009).  
 Plasmids can be divided into four major portions: one is involved in replication, one 
in conjugation, a third section serves unknown functions and the fourth is a likely 
pathogenicity island.  
Replication region: 
ORF41 to ORF61 of the plasmid appears to be involved in replication and partition 
(Takai et al. 2000). This region was found to contain the putative ori (origin of 
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replication) during studies conducted on the development of an R. equi-E. coli 
plasmid shuttle vector (Singer & Finnerty 1988). The origin of replication of R. equi 
virulence plasmid has no homology with genes involved in replication; the only 
exception is a gene (ORF50) which is most homologous with the trbA gene (Singer & 
Finnerty 1988). The trbA gene produces a protein that represses both plasmid 
replication and conjugative transfer (Takai et al. 2000).  ORFs (Open Reading 
Frames) that have homology to parA and parB are found in this replication and 
partition region, while parB is unexpectedly present inside the pathogenicity island 
(Takai et al. 2000). Protein domain analysis identified ORF56 as a helix-turn-helix 
regulatory protein (Takai et al. 2000). It seems likely that the other unknown ORFs in 
this large area are also concerned with replication and partition functions, but further 
work is required to confirm the supposition (Takai et al. 2000). 
Conjugation region:  
This region appears to be concerned with conjugation functions, complex functions 
that involve many genes (Takai et al., 2000). It was observed from sequence analysis 
of plasmid p33701 and p103 that the conjugation region includes ORF23 to 40, thus 
including ORF39 which has homology to a Streptomyces integral membrane protein 
which is probably involved in conjugation and ORF40 which has homology to a gene 
in the transfer gene complex of plasmid RP4 (Takai et al., 2000). Protein domain 
analysis of ORF26, which is the largest ORF of the plasmid, identified a domain 
involved in transcriptional regulation, DNA repair or chromatin unwinding and a 
domain characteristic of the C-terminal domain of helicases which are compatible 
with conjugation activities (Takai et al., 2000). ORF30 was found to be homologous 
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to a gene called traA that encodes conjugal transfer proteins (Takai et al., 2000). 
ORF32 is homologous to a gene topA that encodes a putative DNA type 1 
topoisomerase that controls the topology of DNA and is known to have a role in 
DNA transfer during conjugation (Takai et al., 2000). ORF36 was identified to be 
required for its lysozyme-like activity in hydrolysing the polyglycine interpeptide 
bridge of peptidoglycan to assist the conjugation process (Takai et al., 2000).  
Pathogenicity Island: 
A 27,536-bp region between ORF61 and ORF22 has the characteristics of a 
pathogenicity island since it is bounded by insertion elements, contains a block of 
foreign genes (60.8% GC content), contains a tRNA gene (a lysyl-tRNA synthetase 
[lsr2] gene), contains vapA and six other related virulence-associated protein genes 
that are also known as the vap gene family (VapC, VapD, VapE, VapF, VapG, VapH) 
(Takai et al. 2000). Following phagocytosis of R. equi by macrophages the genes in 
the variable region (VR) of the virulence plasmid are highly expressed (Ren and 
Prescott, 2003). Studies that showed deletion of vapA gene, which lies within the 
variable region, renders the resulting strain avirulent (with no virulence plasmid), it is 
therefore believed that the VR is a pathogenicity island that contains genes essential 
for virulence (Jain et al., 2003).  
1.4.3 Virulence Plasmids Isolation Difficulties 
1) Plasmids may exist in multiple copies and are lost after repeated passages of 
bacteria in broth culture (von Bargen & Haas 2009). Therefore even when 
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strains are found to be plasmid positive initially and are stored at -80ºC, they 
might lose plasmid when thawed and grown on agar or in broth. 
2) Isolating the 80-90kb plasmids from R. equi has been difficult due to their low 
copy numbers owing to their large size, thus repeated attempts have been 
necessary (Tkachuksaad & Prescott 1991). Because of a low copy number, it 
is possible that some strains classified as plasmid negative by identification 
techniques might actually contain plasmids. 
3) Rhodococcus bacteria are surrounded by thick and lamellar polysaccharide 
capsules that are antigenically variable (Prescott 1991). This makes it difficult 
to lyse the cells during plasmid isolations which in turn results in fewer or 
none isolated plasmids. 
1.4.4 Vap Evolution 
As mentioned earlier the VapB and the VapA-encoded plasmids have found to 
contain 6 vap family genes (vapJ, vapK1, vapK2, vapM, vapL and vapB) and (vapC, 
vapD, vapE, vapG, vapH, vapF and vapA) respectively (Letek et al. 2008; Monego et 
al. 2009). Figure 1.4 shows a phylogenetic tree for the mature Vap proteins using the 
amino acid p-distance model (Letek et al. 2008) thereby pointing out the evolutionary 
relationships between vap genes in VapA and those in VapB plasmids. Comparing 
the genetic structures and linkage results of the pathogenicity island from 
pVAPB1593 and pVAPA1037 (previously published plasmid sequences obtained 
from GenBank) the authors were able to reconstruct a model for evolutionary 
dynamics of the vap multigene family (Figure 1.5) which showed that VapA and 
VapB seem to be divergent allelic variants of the same ancestral gene (Letek et al. 
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2008). It has been suggested that the vap Pathogenicity island which was acquired via 
lateral gene transfer by an ancestral plasmid, later evolved by vap gene duplication 
and sequence diversification and adapted to specific hosts after plasmid acquisition 
(Letek et al. 2008). In order to analyse host specificity, VapB deletion strains can be 
changed to VapA and similarly virulence in mice can be altered from intermediate to 
high by interchanging VapB with VapA (von Bargen & Haas 2009). Evolutionary 
comparisons of VapA and VapB will help gain understanding regarding Vap protein 
functions, offer insights into R. equi virulence mechanisms and in turn aid vaccine 
development.  
 
 
Figure 1.4: Phylogenetic tree of vap multigene family. It was constructed from a 
ClustalW alignment of the mature Vap proteins encoded by pVAPB1593 and 
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pVAPA1037. For the analyses, a full-length VapF protein was reconstructed by 
correcting the two frameshift mutations in the 3' region of the gene. Bootstrap values 
(10,000 replicates) are shown at the nodes and the bar indicates genetic distance 
(Letek et al. 2008). 
 
 
Figure 1.5: Map of the evolutionary dynamics of the vap multigene family. The 
straight arrows connect the vap genes that are presumably derived from vertical 
evolution of a common ancestor.  The genes connected by cured arrows were 
probably originated from gene duplication. The asterisks denote degenerate vap  
genes i.e. one gene of each of the duplicated vap IE and vap CF is undergoing decay 
(Letek et al. 2008). 
1.4.5 Heterogeneity in R. equi strains 
In a study by Soedarmanto et al. (1998) heterogeneity among bacteria was found 
when they were subjected to DNA-fingerprinting. It was performed by 
macrorestriction analysis of chromosomal DNA of bacteria by Pulsed-field gel 
electrophoresis (PFGE) (Soedarmanto et al. 1998). DNA-fragments revealed DNA-
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restriction patterns that were different for most isolates investigated, indicating that 
different farms seemed to be contaminated with various R. equi clones (Soedarmanto 
et al. 1998). In only one of six farms studied did all R. equi isolates have identical 
DNA-fingerprints; however most isolates did not contain plasmids (Soedarmanto et 
al. 1998). It would be worthwhile using the same techniques for strains that have 
virulent plasmids. In another study, genotypic variation among virulence plasmids 
was investigated in 543 foal isolates from five different countries (Takai 1999). 
Restriction Fragment Length Polymorphisms (RFLP) revealed that isolates from 
Canada and Argentina contained either an 85-kb type I or an 87-kb type I plasmid; 
isolates from Australia contained mostly an 85-kb type I plasmid; isolates from 
France contained either an 85-kb type I, an 87-kb type I or an 85kb-type II plasmid; 
Japanese isolates did not contain any of the three types instead they revealed 87-kb 
type II or a 90-kb plasmid, thus there seemed to be differences in geographical 
distribution of the 5 virulence plasmids obtained (Takai 1999). A global surveillance 
of virulent R. equi might reveal more about the evolution of horses and possibly the 
transmission of virulent R. equi using plasmid profiles. 
1.4.6 Virulent R. equi Epidemiology  
Brazil: The prevalence of virulent Rhodococcus in clinical isolates was investigated 
in foals obtained from seven horse breeding farms in the south of Brazil (Ribeiro 
2005). Three types of plasmids (85-kb type I, 87-kb type II and 87-kb type III) were 
described based on the restriction enzyme digestion patterns of the isolated plasmids 
in order to gain more information about the vap gene family and the antigens 
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associated with R. equi (Ribeiro 2005). This has importance in exemplifying the 
epidemiological and pathogenic nature of the disease in equines. 
Japan: Virulent R. equi in Japan were found to contain five distinct plasmid types 
based on EcoRI restriction digestion fragments of plasmids (87-kb type II, 90-kb type 
I, 90-kb type II, 90-kb type III, 90-kb type IV) which were in agreement with the 
dispersal of the native horses over a period of time thus providing insight into the 
origin, ancestry and dispersal of R. equi (Takai et al. 2001b). 
Korea: Restriction enzyme digestion patterns of Plasmid DNA extracted from foal 
isolates obtained from four Jeju farms in Korea showed the presence of two closely 
related plasmid types (Takai et al. 2003). These profiles, compared with those found 
in Japan, suggested a common origin and ancestry for isolates from both countries 
and this is supported by the fact that native horses both countries originated from the 
Mongolia horse (Takai et al. 2003).  
Germany:  Four different restriction patterns were observed in VapA positive 
isolates from a horse breeding farm in Germany, with the majority of the infected 
foals displaying three subtypes of the VapA positive R. equi. This characterisation 
was carried out in the hope of gaining more information regarding the route and 
source of infection.  
Texas, U.S.A: Virulent R. equi isolated from three farms in Texas revealed the 
presence of at least 4 different virulence associated plasmids based on RFLPs: 85-kb 
type I, 87-kb type I, 85-kb type III and 85-kb type IV (Takai et al. 2001).  
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The majority of the VapA positive R. equi that infect foals seems have the 85-kb type 
I plasmids (Venner et al. 2007). The additional DNA present in the 87- and 90-kb 
types is thought to be the result of insertion of mobile genetic elements (Takai et al. 
2000). The characterisation of VapA virulence plasmids from R. equi in New Zealand 
will provide an understanding regarding the ancestry and origin of R. equi isolates, 
the pathogenicity of virulent factors, the genetics of R. equi and eventually some 
information on vaccine development. Since the first horses brought to New Zealand 
were from Australia, it is likely that the R. equi plasmids are of similar origin but that 
remains to be investigated. Most Australian R. equi isolates carry 85-kb type I and 
87-kb type I plasmids and majority of virulent R. equi that infect foals in general 
carry 85-kb type I plasmids (Venner et al. 2007) and since there also seems to be a 
geographical correlation for accumulation of certain plasmid types (von Bargen & 
Haas 2009) it can be predicted that R.equi isolates in New Zealand would carry 
plasmids similar to the Australian type. Although plasmids have successfully been 
isolated in a number of studies, it has been a somewhat painstaking process involving 
testing of a variety of modifications to existing methods and this is discussed below. 
1.5 Methodology 
The methods of plasmid isolation used generated a large amount of chromosomal 
DNA and, on some occasions, small amounts of plasmid DNA. Because of the low 
relative amounts of plasmid DNA, banding patterns produced with restriction 
enzymes such as EcoR1 appeared to be very faint and the lane in the gel had smears 
of DNA thus showing that the plasmid product was not clean.  If the plasmid band 
was cut out from the gel, purified and sequenced there was still a high probability of 
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not being able to repeat the obtained result, even after sequencing. It would be futile 
to use restriction enzyme digests of purified plasmid samples to characterise them 
since all isolations would have different levels of purity and that could obscure 
banding patterns of digests thereby showing RFLPs in plasmids without there being a 
true difference between the isolated plasmids. 
                       The primary benefit of this research is to the horse breeding industry of 
New Zealand. Our main aim was to find out if based on R. equi plasmid differences 
there can be multiple subtypes of R. equi in one farm. It not only provides a head start 
in successful growth of R. equi from foal nasal swabs but also in the recognition of 
virulent R. equi and an attempt at using a variety of methods to isolate virulence 
plasmids, some of which proved successful but owing to the nature of the plasmids 
were unreliable, even when repeated under exactly the same conditions. Successful 
isolations were required for the characterization of the plasmids which could help 
find differences in plasmids thus improve our understanding about plasmid function 
and its virulence. However, a more user-friendly and reliable way of plasmid 
characterisation was necessary. It aimed to characterise plasmids by looking at 
approximately 1kb highly variable regions within the plasmid. Four published 
plasmid sequences obtained from GenBank (accession numbers: AM947676, 
AP001204, AF116907 and AM947677) were aligned and a 1000bp area of high 
variation amongst the sequences was selected. Forward and Reverse primers were 
designed for a products that would be roughly 920bps. Comparison of sequences 
from PCR amplification of Plasmid isolations as well as those from DNA isolations 
showed the same sequence results. Therefore sequencing was continued with PCR 
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amplified product from isolated DNA not only because it is quicker and easier but it 
is also more reliable than plasmid isolations. 
1.6 Conclusion 
Although R. equi is a disease of major economic importance to the horse breeding 
industries around the world the exact figures of financial losses in New Zealand are 
unknown.  However, estimates from an Australian study can give an idea regarding 
the costs involved in diagnosis and treatment of infection. An RIRDC project on 
disease surveillance estimated the cost to be roughly AU$370 per case thus 1% of 
foals being infected with R. equi can pose an annual cost of about AU$3-4 million 
(Muscatello et al. 2006a). The breeding and racing of thoroughbreds in New Zealand 
is as much a part of its history and culture as is the development of dairy herds that 
produce export wealth to the community. Thoroughbred horses raised in New 
Zealand are amongst the most sought after in the world as they have been known to 
consistently outperform their competition in every country they race.  Studies have 
shown that foals affected with R. equi perform poorer as race-horses than unaffected 
one‟s thus posing economic losses to New Zealand‟s horse breeding industry. The 
suggested methodology of comparing RFLP patterns of variable regions will not only 
give more insight into epidemiology of R. equi infections here in New Zealand but 
also allow the industry to devise management strategies to minimise exposure to the 
bacteria. 
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2 Research Paper 
The identification, isolation and partial characterisation of VapA-encoding 
virulence plasmids in Rhodococcus equi found in New Zealand. 
2.1 Abstract 
Rhodococcus equi (R. equi) is a facultative intracellular bacterium that survives and 
multiplies within macrophages by establishing a niche inside host cells and causing 
severe pyogranulomatous pneumonia in foals. In foals, virulence is associated with 
the presence of 85-90kb plasmids carrying the vapA gene that encodes VapA protein. 
VapA primers have been used as genetic markers to identify these virulence plasmids. 
To date, twelve different types of VapA-encoding virulence plasmids have been 
described. Epidemiological studies of America, Australia, Korea, Japan and some 
other countries in Europe have revealed that more than one subtype can exist within a 
particular country or even within a particular farm. However the genetic diversity 
amongst VapA-encoding virulence plasmids in R. equi found in foals in New Zealand 
is not known. This study investigates a highly variable region found in virulence 
plasmids in R. equi from a farm in New Zealand using restriction digestion and 
sequence analysis techniques. Results from the analyses of 21 VapA-encoding 
virulence plasmids suggest the existence of two significantly distinct sequences PI 
and PII. Owing to geographical accumulation of plasmid types and the fact that PI 
sequences were found to be almost identical to previously published 85-kb type I 
plasmid sequences from GenBank there seems to be evidence for the presence of both 
the 85-kb type I plasmids and another type in populations of VapA-encoding virulent 
R. equi in foals in New Zealand. 
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2.2 Introduction 
Rhodococcus equi (R. equi), previously called Corynebacterium equi was first 
described by Magnusson in 1923 based on an isolate from the lung of an infected foal 
(Takai 1997). R. equi cause infections in foals less than 4 months old due to their 
compromised immunity (Tkachuksaad & Prescott 1991). It has been ranked as among 
the four most important disease problems in the horse industry (Muscatello 2009) 
causing fever, respiratory distress, pulmonary lesions and chronic pus-filled lung 
abscesses, which are characteristic of severe pyogranulomatous pneumonia (Lavoie et 
al. 1994). R. equi are characterised by the presence of 85-90-kb virulence-associated 
plasmids that encode 15- to 17-kDa antigens (VapA) (Venner et al. 2007). Twelve 
different VapA-encoding plasmid types (85-kb types I to IV, 87-kb types I to III, and 
90-kb types I to V) have been described based on Restriction Fragment Length 
Polymorphisms (RFLPs) from foals around the world (Venner et al. 2007; von 
Bargen & Haas 2009).  Pyogranulomatous pneumonia caused by R. equi infections is 
estimated to affect up to 17% of foals worldwide (Elissalde et al. 1980). In Australia 
1-10% of foals are affected and has mortality rates usually less than 1% due to 
antibiotic treatment; yet, in some farms mortality rates as high as 20% or more can be 
found (Muscatello et al. 2006b).  R. equi infrequently infects other animals such as 
pigs, goats and cattle, and these infections are caused by R. equi isolates with the 
presence of VapB-encoding plasmids (Ocampo-Sosa et al. 2007). R. equi is 
increasingly responsible for AIDS-associated pneumonia in HIV-infected individuals, 
affecting approximately 10-15% of immunocompetent patients (Gabriels et al. 2006). 
Foals with clinical disease are found to have high concentrations of R. equi in their 
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faeces thus faeces from foals is thought to be the main source of soil contamination 
(Muscatello et al. 2006a). It was observed that when the population of virulent R. 
equi increases there is also an increase in inhalation of R. equi from the soil (Takai 
1997). R. equi multiples exceptionally well during the temperate spring and summer 
months therefore minimising the time foals spend in laneways and holding pens - 
where areas are covered with dry and acidic soils - can help reduce exposure of foals 
to R. equi (Muscatello et al. 2006a). It is suggested that direct foal-to-foal 
transmission is unlikely. CD4+ and CD8+ lymphocytes provide protection against R. 
equi infection thus clearance of infection in adult horses is due to production of these 
lymphocytes (Nerren et al. 2009a). Neutrophils play an important role in resistance to 
infection with R. equi and may also have a protective effect by forming a link 
between adaptive and immune responses (Nerren et al. 2009a). However, 
understanding the mechanism of innate and adaptive immunity and the reasons why 
some foals are more susceptible to R. equi infection than others will provide helpful 
information for vaccine development. R. equi is usually resistant to Beta-lactam 
antibiotics and current treatment involves the usage of a combination of erythromycin 
estolate and rifampin (Kedlaya et al. 2001; Jacks 2003). The intravenous 
administration of hyperimmune plasma (HIP) can provide passive immunity to 
treated foals and also reduce the incidence of pneumonia. Nonetheless, it is expensive 
and labour intensive to administer and not universally effective. 
               R. equi have a characteristic appearance after 48 h in culture and develop 
irregularly round, smooth, mucoid, glistening, semitransparent, salmon pink to yellow 
coloured and coalescing colonies (Prescott 1991). Along with the phenotypic 
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identification of R. equi 16S rRNA sequencing has been generally accepted as a 
means for species differentiation. The gene sequence for 16S rRNA is largely 
phylogenetically conserved therefore variable regions in its sequence can be 
characteristic of particular organisms (Bell et al. 1996). They amplify a 441-bp 
segment of DNA from all R. equi strains (Sellon et al. 2001) and have been used in 
this study and others to confirm that the visually identified isolates belong to R. equi. 
A plasmid –typing scheme described by (Ocampo-Sosa et al. 2007) suggests that the 
presence or absence of the plasmid genes traA (959-bp)[A conserved gene for 
plasmid transfer shown to be functional in other Rhodococcus species(Yang et al. 
2007)] and the genes vapA (286-bp) and vapB (477-bp) determine virulence in 
Rhodococcus species (Ocampo-Sosa et al. 2007). Strains that have the characteristic 
traA
+
 vapA
+
 vapB
-
 are found in isolates from sick foals (Ocampo-Sosa et al. 2007; 
von Bargen & Haas 2009). The expression of VapA is thermoregulated and pH 
regulated, occurring at temperatures over 32 ºC and pH of 5.0 (Takai 1991b, 1999; 
Benoit et al. 2001, 2002). Oxidative stress and the concentration of calcium and 
magnesium are also known to control expression of VapA gene and other genes in the 
pathogenicity island (Wall et al. 2005). VapA-encoding plasmids are 85-90 kb in size 
and have been studied intensely due to their central role in virulence (Jain 2003). 
These plasmids belong to the CURV (conjugation-unknown function-
replication/partition-variable region) family of plasmids, the variable region contains 
the „pathogenicity islands‟ and hence is a region of interest (von Bargen & Haas 
2009). The plasmid is known to essential for multiplication in macrophages and by 
enhancing cytotoxicity is able to allow prolonged inhibition of phagosome maturation 
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(Hondalus 1994; Giguere et al. 1999; Luhrmann et al. 2004)The vap gene family of 
VapA-encoding plasmids includes genes vapC, vapD, vapE, vapG, vapH, vapF and 
vapA (Letek et al. 2008; Monego et al. 2009). A second type of plasmid, the VapB-
encoding plasmid contains the vapB gene which is structurally homologous to the 
vapA gene, this VapB plasmid has been isolated from pigs and AIDS infected patients 
(Luhrmann et al. 2004).Along with some evolutionary reasons for the presence of 
different forms of the virulence-associated proteins, an observation suggests the 
involvement of lipid modifications. It has been suggested that the vap pathogenicity 
island which was acquired via lateral gene transfer by an ancestral plasmid, later 
evolved by vap gene duplication and sequence diversification and adapted to specific 
hosts after plasmid acquisition (Letek et al. 2008). Evolutionary comparisons of 
VapA and VapB will help gain an understanding regarding Vap protein functions, 
offer insights into R. equi virulence mechanisms and in turn supply information 
required for vaccine development.  
           A macrorestriction DNA analysis of R.equi by Pulsed-field gel electrophoresis 
(PFGE) indicated that different farms seemed to be contaminated with various R. equi 
clones.  In fact, of the six farms studied only one farm showed identical R. equi 
isolate DNA fingerprints; however, most isolates did not contain plasmids 
(Soedarmanto et al. 1998). In another study genotypic variation among virulence 
plasmids was investigated in 543 foal isolates from five different countries (Takai 
1999). Restriction Fragment Length Polymorphisms (RFLP) revealed that isolates 
from Canada and Argentina contained either an 85-kb type I or an 87-kb type I 
plasmid; isolates from Australia contained mostly an 85-kb type I plasmid; isolates 
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from France contained either an 85-kb type I, an 87-kb type I or an 85kb-type II 
plasmid; Japanese isolates did not contain any of the three types instead they revealed 
87-kb type II or a 90-kb plasmid, thus there seemed to be differences in geographical 
distribution of the 5 virulence plasmids obtained (Takai 1999). A global surveillance 
of virulent R. equi might reveal more information regarding the evolution of horses 
and possibly the transmission of virulent R. equi using plasmid profiles.  
              The purpose of the study was to find out if multiple subtypes of R. equi can 
be found within one farm in New Zealand. Isolating the 85-90kb plasmids from R. 
equi has been difficult due to their low copy numbers owing to their large size, 
existence in multiple copies which are lost after repeated passages of bacteria in broth 
culture and being surrounded by thick and lamellar polysaccharide capsules which are 
difficult to lyse (Prescott 1991; Tkachuksaad & Prescott 1991; von Bargen & Haas 
2009). Based on R. equi plasmid RFLPs and sequence analysis of a variable region 
from 21 VapA-encoded plasmids two distinct types of sequences were found 
suggesting polymorphisms in population of R. equi in New Zealand.  
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2.3 Materials and Methods 
 
Collection, growth and isolation of Bacteria 
Nasal swabs of 40 foals with clinical R. equi infection obtained by clinical vets were 
used in this study.  Swabs were stored at -80ºC, defrosted at room temperature when 
required and individual swabs were streaked on NANAT selective media and grown 
at 37 ºC for approximately 4-5 days. R. equi colonies were identified based on their 
colony morphology and subsequent confirmation via PCR. Three R. equi colonies 
from each plate were numbered and streaked onto BHI (Blood Heart Infusion) agar 
and grown at 37 ºC for 48 h (hours). 
 
PCR and Gel Electrophoresis to identify virulence plasmid positive bacteria 
Each single colony was inoculated in 100 µl of 20% PEG (Polyethylene glycol) lysis 
solution for quick crude DNA extraction and heated at 95 ºC for 10 min. 2 µl of each 
DNA sample (400-600 ng/µl) was added to a 20 µl reaction of PCR (Polymerase 
Chain Reaction) in order to amplify DNA. PCR was carried out on a Peltier Thermal 
Cycler DNA engine
®
 (BIO-RAD) or on a Peltier Thermal Cycler PTC-200 (BIO-
RAD). A 16S primer that corresponded to its gene was used as genotypic 
confirmation for the phenotypic selection of R. equi isolates. VapA (specific marker 
for the virulence plasmid vapA gene) and TraA (specific marker for all R. equi 
plasmids) primers were used for identifying the presence of virulence plasmids in 
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samples. Primers used in this study were purchased from Invitrogen and designed 
using Primer3 Input-version 0.4.0 (Whitehead Institute for Biomedical Research; 
http://frodo.wi.mit.edu/primer3/). Platinum Taq DNA Polymerase (Invitrogen, New 
Zealand) or i-star Taq (INtRON Biotechnology) was used for DNA cycling. Cycling 
conditions with VapA primer were as follows: 95 ºC for 2 min, 39 cycles of 95 ºC for 
20 s, 55 ºC for 20 s, 72 ºC for 30 s and a final step at 68 ºC for 5 min. For TraA the 
temperature in the third step was increased to 60 ºC and the time was increased from 
20 s to 1 min. 10 µl of each sample was subjected to electrophoresis in a 1% Agarose 
gel (containing 0.5 µg of Ethidium Bromide) at 110V using 1 X SB Buffer (Sodium 
Borate) and visualised under a UV transilluminator (AIRPRO Scientific Limited).  
 
DNA Extraction 
Tubes were labelled and 350 µl of Lysis Solution A (0.1M Tris, 0.5 SDS, 40mM 
EDTA, 100 mM NaCl) was pipetted into each tube (1.7 mL „Eppendorf‟ tubes). 
Single colonies were scraped from the BHI plates that were incubated at 37ºC using a 
loop and were put into their respective tubes. Samples were placed in a thermomixer 
(Eppendorf) at 95ºC at 650rpm for about 10-15 min. 350 µl of Lysis Solution B (5M 
LiCl) was added into each tube after which they were inverted a number of times. 750 
µl of Chloroform was added to each tube which was then vortexed for a few seconds 
before being put on a rotator for 10 min. The tubes were centrifuged at 16k for 15 
min which created the division of the DNA and cell-debris pellet. The top aqueous 
layers of each tube containing the DNA were pipetted out into fresh tubes. Roughly 
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equal amounts of 100% isopropanol were added to each of the tubes and were 
inverted about 5 times. The tubes were left on the bench at room temperature for 20 
min to allow DNA precipitation. They were centrifuged at 16k for 15 min and the 
isopropanol was poured out from the tubes. 1ml of 70% ethanol was added to each 
tube and then spun again in the centrifuge at 16k for 5 min. The ethanol was poured 
out; the tubes were spun as before in the centrifuge for a couple of minutes after 
which the excess ethanol was pipetted out. 50 µl of TE (100mM Tris-Cl, 10mM 
EDTA) was added to each tube and left on the bench for about 30 min. They were 
then put in a 37ºC shaker for 30 min, vortexed to allow mixing then the DNA 
concentration was measured using a NanoDrop (ND-1000 Version 3.5.2 produced by 
Coleman Technologies Inc for NanoDrop Technologies). 
 
Plasmid Isolation 
Of all the plasmid Isolation methods tried the following seemed to be the most 
successful, it was called Method E. A few µL of broth stored at -80ºC was streaked 
onto plates and colonies grew overnight. Loops full of bacteria were transferred to 10 
mL of BHI broth which were grown overnight at 37ºC in a shaking incubator. Tubes 
were labelled, 90 µl of TE and 10 µl of lysozyme (70 mg/mL) was added to each 
tube. The contents of the tubes were mixed well by running them along PCR trays. 
They were put in a thermomixer at 37ºC for an hour. 600 µl of Tens Buffer (0.1M 
NaOH, 0.2% SDS, 1mM EDTA, 10mM Tris pH 7.5) was added to each tube, which 
were then put on a rotator for about 30mins. 300 µl of 3M NaOAc was added; the 
tubes were mixed by inverting a few times and then spun in the centrifuge at 16k for 
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5 min. The supernatant was put in a fresh tube without disturbing the pellet. 600 µl of 
phenol: chloroform (1:1) was added to each tube and then put on a rotator for 10 min. 
They were spun in a centrifuge at 16k for 10 min after which the top layers of the 
contents were put into fresh tubes. Equal amounts of 100% Isopropanol or 20% PEG 
(20g PEG 8000, 14.8g NaCl/100 mL H2O) was added to each tube, they were 
inverted a few times then left on the bench for about 10 min to allow precipitation. As 
before, they were spun in a centrifuge at 16k for 10 min. The Isopropanol was tipped 
out of the tubes without disturbing the pellet. 350 µl of Lysis Buffer, 350 µl of 5M 
LiCl and 80 µl of CTAB (10g CTAB, 4.1g NaCl/100 mL H2O) was added to each 
tube and then heated at 65ºC for 10 min. The tubes were vigorously shaken followed 
by addition of equal volumes of Chloroform. They were spun in the centrifuge at 16k 
for 14 min. The top layer was removed and put into separate tubes as before. Equal 
volumes of Isopropanol was added, the tubes were left on the bench for 10 min and 
then spun at 16k for 10 min. The isopropanol was poured out leaving behind the 
pellet which was washed twice with 1 mL of 70% Ethanol. TE was added to each 
tube depending on the size of pellet obtained. 
 
PCR and Restriction Digestion of highly variable regions 
Four plasmid sequences available from NCBI GenBank (Accession numbers: 
AM947676, AP001204, AF116907, AM947677) were aligned using software called 
ClustalX (EMBL-EBI). Regions displaying high variation were sought out in order to 
select an approximately 1Kb region showing maximum differences in base pairs. One 
particular highly variable region was found and primers were designed. Two primers: 
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74 and 76 (74 being 50 bp larger than 76) were designed and used in PCR to amplify 
the region of interest. PCR conditions were as follows: 95 ºC for 2 min, 35 cycles of 
95 ºC for 20 s, 60 ºC for 20 s, 72 ºC for 30 s and a final step at 68 ºC for 5 min.  
Samples were digested with restriction enzyme HindII (Boehringer Mannheim) or 
HincII (New England BioLabs) and an 11µl volume of digested DNA was 
electrophoresed in TAE buffer at 70V for 1.5 h in 2% agarose gels. 
 
Sequencing Data Analysis 
The 20 DNA samples that were sent out for sequencing to the Waikato DNA 
Sequencing Facility were extracted from gels using the Zymoclean Gel DNA 
Recovery Kit
TM
. The facility offers a DNA sequencing service based on the 
Amersham Biosciences MegaBACE DNA Analysis System that utilizes dye 
terminator chemistry. Electropherograms data obtained were aligned using program 
ClustalX from EBI web server (http://www.ebi.ac.uk/Tools/clustalw2/index.html). 
Comparisons of sequences were done using BLAST (Basic Local Alignment Search 
tool) (http://blast.ncbi.nlm.nih.gov/Blast.cgi) at the server of the National Centre for 
Biotechnology information.  
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VapAF  GACTCTTCACAAGACGGT (Ocampo-Sosa et al. 2007) 
VapAR  TAGGCGTTGTGCCAGCTA (Ocampo-Sosa et al. 2007) 
TraAF  AGAGTTCATGCGTGACAACG (Ocampo-Sosa et al. 2007) 
TraAR  GTCCACAGGTCACCGTTCTT (Ocampo-Sosa et al. 2007) 
16SF  TCGTCCGTGAAAACTTGGG (Sellon et al. 2001) 
16SR     CGACCACAAGGGGGCCGT (Sellon et al. 2001) 
74F CCGGTGTGTACGTGTACCTG  
74R ATCCGTAGTCGAGCATCACC  
76F CCCTAGACCACGCAATCG  
76R ATCCGTAGTCGAGCATCACC  
 
Table 1: Primer sequences used in PCR amplifications and sequencing. F- Forward 
R- Reverse 
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2.4 Results and Discussions 
 
Bacteria Recovery and Storage  
The repeated transfer of bacteria from one media to another or storage of bacteria on 
agar in a refrigerator over a period of time (von Bargen & Haas 2009) was 
responsible for the large VapA plasmids getting expelled from the bacterial cell. Thus 
when bacteria grown in NANAT media were transferred to BHI plates and finally to 
BHI broth plasmids were lost from the bacterial cells. Thus a more efficient way to 
store positive samples was to use half the single colony to do a quick PEG Lysis, 
PCR and confirm the presence of plasmids then use the other half of the virulence 
plasmid (VP) positive isolate to grow VP positive isolates in broth and freeze them at 
-80 ºC until required.  10 mL of bacteria was frozen in approximately 1 mL of 
glycerol which allows preservation of bacteria and prevents damage that can be 
encountered during freezing or thawing of samples. Freezing the VP positive isolate 
in the initial steps was essential so that once the positives were found only those 
samples were used for DNA /Plasmid isolation. Since plasmids were getting lost from 
the samples, storing plates was not an option thus one had to grow only a few 
samples at a time so that they could be dealt with on the same day as any plates left 
for another day or two could potentially be void of plasmid. This was very time 
consuming but there was a better chance of preserving plasmids in isolates for use in 
further experiments.  
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Identifying Rhodococcus Bacteria 
The growth of nasal swabs on NANAT selective media plates allowed the visual 
identification of R. equi based on the salmon pink to yellow coloured mucoid 
morphology of the colonies as described by (Prescott 1991). An occasional absence 
of R. equi growth on plates was observed due to the strength of the antibiotics used or 
their higher concentration in certain plates due to the media not being mixed properly. 
This was ensured by increasing the amount of media while maintaining the antibiotic 
concentration and doubling the time used for mixing it. Use of NANAT selective 
media successfully eliminated the growth of undesirable bacteria since the antibiotics 
used have the following activity. Polymyxin B is used against resistant gram negative 
as it binds to cell membrane and alters its structure by making it more permeable, 
Naladixic acid is known to be effective against gram positive and gram negative 
bacteria but if present in high concentrations it kills bacteria instead of inhibiting its 
growth (Monique et al. 2003), Novobiocin is a potent inhibitor of DNA gyrase and is 
an effective antistaphylococcus agent (Walsh et al. 1983) and Cyclohexamide is 
effective against eukaryotes such as yeast. The 16S rRNA gene is highly conserved 
between different species (Coenye & Vandamme 2003) and thus 16S primers which 
amplify a 441-bp segment of DNA from all strains of R. equi (Sellon et al. 2001) 
were used in this study to confirm the visual identification of R. equi as seen below in 
Figure 2.1. 
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Figure 2.1: R. equi identification of 5 isolates. 16S primers were used in polymerase 
chain reaction.  
 
Identifying Virulent Plasmid (VP) Positive Bacteria based on traA or vapA genes 
The results obtained from the PEG Lysis of bacterial cells and Polymerase Chain 
Reaction (PCR) that was carried out with the VapA (Forward and Reverse) or TraA 
(Forward and Reverse) primers to find bacteria carrying the vapA or traA genes 
respectively (as shown in Figure 2.2 and Figure 2.3). VapA is indicative of the 
presence of R. equi virulence plasmids whereas TraA is indicative of the presence of 
large plasmids (Ocampo-Sosa et al. 2007). 50 out of 105 isolates tested by VapA 
primers were found to be VP positive as shown in Table 1 below.  
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Foal tested for vapA/traA       Result   
      1 2 3 
B1 Victor Supreme 08‟      - - - 
B3 Lislea Lass 08‟     - - - 
B4 Invogorate 08‟     - - - 
B5 Girl of your Dreams 08‟     - + + 
B7 Angel of Tarcoola 08‟     + + + 
B8 Got to be September 08‟     - - - 
B9 Shy Angel 08‟     - + + 
B11 Jaquie N 08‟     + + + 
B12 Immortality 08‟     - - - 
B13 Charmed life 08‟     - - - 
B14 Susie Sands 08‟     + + + 
B15 We Love to Party 08‟     - + - 
B16 Cyclone Vance 08‟     - - - 
B17 Idle Eve 08‟     - + - 
B18 Culleys Asset 08‟     + + - 
B19 Tania Bromac 08‟     - + - 
B20 Foxy Mama 08‟     + + - 
B22 Parisian Pearl 08‟     - - - 
B23 Splendid Dreams 08‟     + + + 
B25 Ally 08‟     + - + 
B26 Speedy Star 08‟     - - + 
B30 Socky Sweet Heart 08‟     + + + 
B31 Twilight Chaser 08‟     + + + 
B32 Dainty Falcon 08‟     + + - 
B33 Perfecta Lobell 08‟     + + - 
B34 Trumphant France 08‟     - + + 
B35 Geld Bromac 08‟     - + - 
B36 Poppy 08‟     + + + 
B37 Classic Ace 08‟      - - - 
B38 Darsia 08‟     + - + 
B39 Rosemary Grace 08‟     + - - 
B40 Explosive Atom 08‟     + + - 
B41 Party Baby 08‟     - - - 
B42 A little more magic 08‟     + + - 
B43 In Hollywood 08‟     - - - 
 
Table 2: R. equi isolates tested for presence and absence of the virulence plasmid. 
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Figure 2.2: R. equi virulence plasmid detection of isolates. This was based on 
polymerase chain reaction with VapA primers.  
 
 
Figure 2.3: R. equi virulence plasmid detection of isolates. This was based on 
polymerase chain reaction with TraA primers.  
 
The VapA amplification of 105 R. equi isolates is located in the Appendix 5.3: Gel 
Photos section of this thesis. 
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Plasmid Isolation 
Large plasmids are difficult to see due to the obscuring by tailing of the chromosomal 
DNA, they are very thin and will run behind the chromosomal DNA band in an 
agarose gel (Walker 1984). As shown in figure, Method E was able to yield 
prominent plasmid DNA but unfortunately repeating the obtained result was very 
difficult. Since large plasmids are present in low copy numbers and nocardioform 
actinomycetes are relatively resistant to lysis, low yields of plasmid DNA are often 
found (De la Pena-Moctezuma & Prescott 1995). It was realised that the problem did 
not lie entirely with the methods being used but it was the nature of the plasmid that 
was making the isolations and their visualisations on gels so difficult. Plasmid 
visualisation on electrophoresis gels was quite cumbersome but was achieved for 
some plasmid isolations as observed in Figure 2.4. The supercoiled DNA migrates the 
fastest in the gel due to its tight conformation, followed by nicked DNA and then its 
linear form (Schleef 2001). Restriction digestion with EcoRI/NcoI of isolated plasmid 
showed extremely faint banding patterns and a fair amount of smearing emphasising 
the poor quality of the isolated plasmid, the gel photo is available in the Appendix 
Additional results section. It would be very difficult and time consuming to recognise 
different RFLPs in different plasmids and the difference in the quality of isolated 
plasmids would affect the banding pattern thus the RFLPs would be due to quality 
differences and not actual differences in plasmids. There was a need to find an easier 
way to characterise plasmids based on RFLPs.  
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Figure 2.4: Agarose gel separations of plasmid DNA. These were isolated from 
various isolates of R. equi using a variety of methods and run for 10 hours in an 
electrophoresis gel. 
  
Sequence Alignment 
By aligning sequences of four available plasmids from GenBank (Accession 
numbers: AM947676, AP001204, AF116907, AM947677) a highly variable region 
was observed from which a region that was approximately 1 Kb in size was selected. 
With the exception of AM947676 which encoded VapB the three other plasmids 
encoded VapA. This highly variable region would be used to amplify part of the same 
variable region from DNA extractions/Plasmid isolations from VP positive isolates 
which would yield possible RFLPs when digested with restriction enzymes. Based on 
these assumption 21 VP positive strains were trialled. The sequence alignment of the 
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four plasmids is approximately 200 pages due to the large plasmid sizes and is 
available in section 4 on the CD attached to the back of the thesis. The highly variable 
region selected from the four plasmid alignments for this analysis is highlighted. 
Sequences of the two designed primers based on the variable region of plasmid 
accession number AF116907 which was named p103: 74 and 76 are available in 
section 2 on the CD. The only difference between the primers is that 74 consists of an 
extra 59 bp at the start of the sequence. This region was found to be void of any genes 
and is probably an intergenic region which is less conserved than the other areas but 
had the potential in characterising virulence plasmids if any differences did occur.  
                 It was necessary to see if there was any cross reactivity between genomic 
DNA isolations and plasmid isolations of VP positive isolates for amplification with 
either primers 74 or 76. Figure 2.5 showed no difference in using plasmid isolations 
or DNA extractions for amplification of the variable region with primer 76. Because 
DNA extractions are relatively rapid and more efficient than plasmid isolations they 
were thus the method of choice for the analysis.                  
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Figure 2.5: A comparison of plasmid isolation (PI) and DNA extraction (DNA) of VP 
positive isolate 7.5 with primer 76. 
                                      
 Figure 2.6: Comparison of 4 VP positive isolates. They were amplified with primers 
74 and 76.    
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Figure 2.7: Comparison of restriction digestion of 4 VP positive isolates. They were 
amplified with primers 74 and 76 using restriction enzyme HindII. 
Restriction Digestion 
The region amplified by primers 74 and 76 generated amplicons of sizes 926-bp and 
917-bp respectively. Primers 74 often failed to amplify the region of interest in 
positive samples (as shown in Figure 2.6) and even when the region was amplified it 
wasn‟t always sensitive to the restriction digestion by enzyme HindII , Primers 76 
were a more reliable primer-set in generating amplicons and being digested with the 
restriction enzyme HindII/HincII and thus the preferred primer for the amplification 
of the selected variable region in plasmids (as shown in Figure 2.7). It was noticed 
from Figure 2.7 that R. equi isolate 19.2 had a different restriction digestion pattern 
compared to the three other isolates. This suggested the possibility of RFLPs in the 
isolates. 21 VP positive R. equi isolates were selected and subjected to restriction 
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digestion with HindII/HincII, as shown in the Figure 2.8. Distinct patterns were 
observed, the pattern with DNA bands of lower molecular weight was called PI and 
those with DNA of higher molecular weight was called PII. 13 VP positive R. equi 
isolates belonged to PI and 8 belonged to PII. All R. equi isolates from the same nasal 
swab had the same RFLP patterns and similar sequences. To confirm the observed 
result all 21 isolates were subjected to sequence analysis. Sequencing of many 
samples had to be repeated due to contamination with smaller products generated 
from non-specific binding, excising bands from the gel instead of purifying the PCR 
product solved the problem.  
PI PII 
7.5 31.3 
7.6 19.2 
9.2 36.2 
9.6 36.3 
14.3 40.1 
14.1 40.2 
32.1 42.1 
30.1 42.2 
30.2  
30.3  
39.1  
18.2  
25.3  
 
Table 3: The distribution of PI and PII patterns among 21 VP positive R. equi 
isolates. The numbers refer to the foal number from Table 1.and the decimal points 
refer to strains of bacteria that were found to be positive. 
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Figure 2.8: Restriction digests of 21 VP positive R. equi isolates using enzyme HindII . 
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PI Sequences  
 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage E value 
Max 
ident 
AM947677.1 
Rhodococcus 
vapA-type 
virulence plasmid 
(pVAPA1037), 
strain 103S 1620 1620 100% 0 100% 
AP001204.1 
Rhodococcus 
plasmid 
pREAT701 DNA, 
complete 
sequence 1620 1620 100% 0 100% 
AF116907.2 
Rhodococcus 
virulence plasmid, 
complete 
sequence 1620 1620 100% 0 100% 
AM947676.1 
Rhodococcus 
vapB-type 
virulence plasmid 
(pVAPB1593), 
strain PAM1593 252 252 24% 
5.00E-
68 88% 
 
 
Table 4: An example of a PI sequence producing alignments with published 
sequences. These were generated by the BLAST program. 
 
All PI sequences had query coverage of 100% with a 98 to100% identity with 
plasmids of accession numbers: AM947677.1, AP001204.1, and AF116907.2 that all 
belonged to VapA virulence plasmids of 85-kb type I as shown in Table 4. Since 
query coverage of 24 to 25% was observed with accession number AM947676.1 of 
virulence plasmid VapB as seen in table it is certain that the query sequences are not 
from VapB-encoding plasmids. This data suggested that all PI sequences are a very 
59 
 
close match with the 80, 610 nt VapA plasmids, whose genome sequence are 
available in GenBank and are of 85-kb type I plasmids (Takai et al. 2000). However, 
if published genome sequences of other plasmid types were available to make 
comparisons, our results would be more conclusive. 
 
 
PII Sequences 
 
Accession 
 
Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 394 394 30% 
8.00E-
111 88% 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 224 503 31% 1.00E-59 98% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 224 503 31% 1.00E-59 98% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 224 503 31% 1.00E-59 
 
 
98% 
 
 
 
 
Table 5: An example of a PII sequence producing alignments with published 
sequences. These were generated by the BLAST program. 
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PII sequences unlike PI sequences had low query coverage of 29-37% with plasmids 
of accession numbers AM947677, AP001204 and AF116907 which are VapA type 
plasmids with 98-100% identity. Query coverage of 29-30% and identity of 88-90% 
was observed with plasmid of accession number AM947676 which is a VapB type 
plasmid. There is a possibility that PII sequences are from a different type of plasmid 
but more analysis of other sequences from variable regions of the plasmid and 
comparisons with published plasmid genomes of different types is required to 
confirm this.                                           
 
Sequencing Data Analysis 
Minor single nucleotide polymorphisms (SNPs) were observed in the sequences but 
they were acceptable since the region is highly variable thus less conserved and 
therefore more prone to SNPs. Poor quality in the first 15-20 bases and the 
deteriorating quality of sequencing traces after 700-900 bases was observed in the 
electropherograms of sequences as expected. Hence the first 30 and the last 50 bases 
from each of the sequences were not included in the analysis. Since the region being 
studied was GC-rich i.e. 64% and due to non-specific binding in some samples 
repeated attempts at sequencing were required.  
                 PI sequences were found to have significant matches with three plasmid 
genome sequences,  two of which i.e. plasmid p103 (accession number: AF116907), 
which is 80,609 nt in size and plasmid ATCC3370 pREAT701 (accession number: 
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AP001204), which is 80,610 nt have been found to be virtually identical and both are 
of the 85-kb type I (Takai et al. 2000). The third published plasmid 103S (accession 
number: AM947677) is 100% identical to the two above mentioned plasmids and 
thus must also belong to the 85-kb type I plasmid but comparisons with 87-kb type I 
plasmids is necessary. Due to the fact that most clinical isolates from Australia, 
America and Europe are found to contain either the 85-kb type I or 87-kb type I 
plasmids (Venner et al. 2007), the first horses were brought to New Zealand from 
Australia and that VapA-encoding plasmids of virulent R. equi infecting foals are 
mostly from 85-kb type I plasmids it is quite certain that the PI plasmids are 85-kb 
type I plasmids whereas PII could possibly correlate to 87-kb type I plasmids of any 
of the other types of 85-kb plasmids but more PII sequences need to be compared to 
those of 87-kb type I sequences to reach a valid conclusion but 87-kb type I 
sequences are unavailable. However sequences of PII could have matches with 85 Kb 
or 90 Kb types of plasmids but since the sequences of those too are unavailable in 
GenBank a comparison cannot be made. Selecting other variable regions from 
plasmid alignments and sequencing them can help confirm the observation made in 
this study. From our results it is likely that more than one subtype can exist from 
isolates on a single farm. Characterisation of these plasmids will be a useful tool in 
epidemiological studies. Since the sequence studied did not contain any known genes 
that determine proteins it could be an intergenic region, a regulatory sequence which 
is involved in regulating processes such as transcription or may even contain non-
coding RNAs some of which are involved in maintaining cellular processes such as 
translation. 
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3 Conclusions 
3.1 Summary 
The results of the research presented in this thesis suggest that subtypes of R. equi 
isolates may exist in a single farm in New Zealand.  Based on the fact that two of the 
published plasmid sequences that had significant matches with PI are 85-kb type I 
plasmids, that Australian R. equi isolates are mostly either 85-kb type I or 87-kb type 
I plasmids which were the first horses brought to New Zealand and that most R. equi 
isolates in the world are 85-kb type I it is speculated that a variable region from 
plasmids with PI patterns are 85-kb type I plasmids. This is the first attempt at 
characterisation of the New Zealand R. equi VapA-encoded plasmids. An in depth 
knowledge of the unique characteristics of plasmids and their relatedness of strains 
within the species could define transmission characteristics and possible sources of 
infection in disease outbreaks. 
             Use of a 16S primer provided rapid and accurate species identification 
whereas TraA and VapA primers were good indicators of the presence of virulence 
plasmids and of the presence of VapA-encoded plasmids respectively in R. equi 
found in foal nasal swabs. Studies have provided evidence of geographic diversity 
among isolates of R. equi by discovering twelve different but closely related virulence 
plasmid types from throughout the world.  
            Plasmid isolations were rather tedious thus selecting a variable region for 
analysis as used in this study to uncover plasmid characteristics is an efficient 
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alternative method. Associations between chromosomal differences, virulence and 
plasmid profiles will further evaluate the molecular diversity of R. equi. Analysis of 
the sequences deposited in GenBank provides a starting point for further analysis. 
However, more extensive sequencing of plasmid genomes, their mobile elements and 
sequence ontologies is necessary to address fundamental questions regarding its 
evolution and critical problems such as the spread of antibiotic resistance (Williams 
et al. 2006). 
 
3.2 Future Work and Recommendations 
Results in this study are based on sequence analysis of approximately 1-kb variable 
regions of VapA-encoding plasmids from 21 VP positive isolates of a farm in New 
Zealand. To lend support to the results presented in this thesis, it would be beneficial 
to investigate multiple regions of variability from plasmid alignments. The nasal 
swabs used in this investigation are all from foals in one farm; it would be interesting 
to get swabs from multiple farms to see if there is more variation in R. equi VapA-
encoding plasmids or if the same variation as in this study exists in other farms in 
New Zealand. Factors that influenced the robustness of DNA sequence analysis 
studies included PCR contamination, DNA quality and quantity, GC content of the 
sample, resolution of the genetic markers and non-specific primer binding.  
             Contamination is a common problem when working with PCR especially on 
a daily basis as in this study. Because contamination is potentially expensive and 
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time-consuming it is advisable to aliquot all reagents used, such as primers. 
Contamination can be difficult to ferret out, thus cleaning pipettes, work area and 
regularly changing lab coats and gloves was an essential part of the daily routine to 
keep contamination away. PCR produces results quickly, is very useful for diagnostic 
purposes and it also has the advantage of ruling out R. equi pneumonia in culture-
negative foals that have failed to improve with anti microbial therapy (Sellon et al. 
2001). It may also be useful in monitoring response to therapy and deciding when to 
stop therapy in foals (Sellon et al. 2001). However, at the start of a PCR reaction, 
reagents are in excess whereas template and product are at low enough concentrations 
therefore product renaturation does not compete with primer binding and 
amplification proceeds at a constant rate. When the reaction enters linear phase, 
amplification is variable even among replicate samples this is mainly due to product 
renaturation competing with primer binding. In order to get precision and accuracy, 
when the sample is in constant rate of amplification it is necessary to collect 
quantitative data at that point. This is possible with RT-PCR (Real-Time Polymerase 
Chain Reaction) where analysis of reactions during exponential phase at a given cycle 
number provides several orders of magnitude of dynamic range. Thus RT-PCR can 
be used as quantitative analysis of sample DNA from the variable regions of plasmids 
alignments. Capillary gel electrophoresis to view large plasmids is available which 
allows separation of plasmid structures (supercoiled, linear or nicked DNA) in thin 
capillaries that are filled with liquid polymer solution that have high resolution, high 
sensitivity even when low DNA concentrations are used (Walker 1984). It has been 
suggested that using mCAZ-NB {ceftazidime (20 µg/mL), novobiocin (25 µg/mL) 
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and cycloheximide (40 µg/mL)} media might be more useful than NANAT media,  
due to higher rates of recovery of virulent R. equi from samples (Muscatello et al. 
2006a). 
           When performing plasmid isolations, taking the number of bacterial cells in to 
consideration might give more control over the plasmid yield. Since chromosomal 
DNA reduces plasmid visibility in electrophoresis gels, methods that reduce the 
content of chromosomal DNA in plasmids isolation might be beneficial.  A better 
understanding of the cell wall structure of R. equi will improve our understanding in 
its complexity, its contribution in virulence and possibly improve plasmid isolations. 
Some aspects that can be studies in the future include; designing a reliable vaccine for 
foals that are younger than three months of age, understanding phagosome maturation 
by R. equi (von Bargen & Haas 2009) and infecting non-virulent strains with virulent 
plasmids to understand direct foal to foal transmission and its epidemiological 
relevance. Further research on R. equi virulence determinants discussed in Chapter 1 
is required to fully understand the R. equi virulence mechanism. 
           The murine model of R. equi infection is not a good one, because the route of 
infection in mice does not mimic that in foals. In foals, the respiratory route is the 
route of infection caused by the smaller number of organisms, whereas the route in 
mouse models is intravenous and a large number of organisms are administered 
(Heuzenroeder et al. 2005). A more efficient inexpensive and accurate approach to 
obtain plasmid DNA of sufficient amount and quality to generate libraries remains to 
be found (Heuzenroeder et al. 2005). An important research area for the future will be 
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the analysis of chromosomally encoded proteins and their associations with R. equi 
virulence plasmid factors (von Bargen & Haas 2009). Techniques of gene 
manipulations of R. equi will help discover factors involved in phagosome 
establishment and host cell cytotoxicity. An enormous amount of surface-associated 
proteins have been revealed in the R. equi genome and their possible interaction with 
host cells in the course of infection requires investigation (von Bargen & Haas 2009).   
          Studies in recent years have highlighted the importance of airborne R. equi 
population and ecological factors that facilitate aerosolization of virulent R. equi (i.e. 
soil, moisture, sandy soils and poor pasture cover). Furthermore the growing 
resistance of R. equi to antibiotics emphasizes the importance of vaccine 
development.  A better understanding of R. equi virulence plasmid epidemiology will 
lead to improved strategies for prevention and control of the disease. 
 
 
 
 
 
 
67 
 
4 References 
Anzai T, Wada R, Nakanishi A, Kamada M, Takai S, Shindo Y, Tsubaki S (1997). 
Comparison of tracheal aspiration with other tests for diagnosis of 
Rhodococcus pneumonia in foals. Veterinary Microbiology 56, 335-345. 
 
Barton M, Embury D (1987). Studies of the pathogenesis of Rhodococcus infections 
in foals. Aust. Vet. T. 11, 332-339. 
 
Bell KS, Philp JC, Christofi N, Aw DWJ (1996). Identification of Rhodococcus using 
the polymerase chain reaction. Letters in Applied Microbiology 23(2), 72-74. 
 
Bell KS, Philp JC, Aw DWJ, Christofi N (1998). A review - The genus Rhodococcus. 
Journal of Applied Microbiology 85(2), 195-210. 
 
Benoit S, Benachour A, Taouji S, Auffray Y, Hartke A 2001. Induction of vap genes 
encoded by the virulence plasmid of Rhodococcus during acid tolerance 
response. Research in Microbiology 152(5), 439-449. 
 
Benoit S, Benachour A, Taouji S, Auffray Y, Hartke A (2002). H2O2, which causes 
macrophage-related stress, triggers induction of expression of virulence-
associated plasmid determinants in Rhodococcus. Infection and Immunity 
70(7), 3768-3776. 
 
Birnboim HC, Doly (1988). Citation Classic - A Rapid Alkaline Extraction Procedure 
for Screening Recombinnat Plasmid DNA. Current Contents/Life Sciences 45, 
12-12. 
 
Blood-Horse P (2009). Rhodococcus. http://cs.bloodhorse.com/blogs/blood-horse-
press-room/archive/2009/03/05/ 
 
Byrne GA, Russell DA, Chen X, Meijer WG 2007. Transcriptional Regulation of the 
virR Operon of the intracellular pathogen Rhodococcus. Journal of 
Bacteriology 189: 5082-5089. 
 
Chaffin MK, Cohen ND, Martens RJ, Edwards RE, Nevill M (2003). Foal-related 
risk factors associated with development of Rhodococcus pneumonia on farms 
with endemic infection. Journal of the American Veterinary Medical 
Association 223(12), 1791-1799. 
 
Coenye T, Vandamme P (2003). Intragenomic heterogeneity between multiple 16S 
ribosomal RNA operons in sequenced bacterial genomes. FEMS Microbiol. 
Lett. 228, 45-49. 
 
68 
 
De la Pena-Moctezuma A, Prescott J (1995). Association with HeLa cells by 
Rhodococcus with and without virulence plasmids. veterinary Microbiology 
46, 383-392. 
 
DeLaPenaMoctezuma A, Prescott JF, Goodfellow M (1996). Attempts to find 
phenotypic markers of the virulence plasmid of Rhodococcus. Canadian 
Journal of Veterinary Research-Revue Canadienne De Recherche Veterinaire 
60(1), 29-33. 
 
Elissalde G, Renshaw H, Walberg J (1980). Corynebacterium equi: an interhost 
review with emphasis on the foal. Comp. Immunol. Microbiol. Infect. Dis. 3, 
433-445. 
 
Finnerty WR (1992). The Biology and Genetics of the Genus Rhodococcus. Annual 
Review of Microbiology 46, 193-218. 
 
Gabriels P, Joosen H, Put E, Verhaegen J, Magerman K, Cartuyvels R (2006). 
Recurrent Rhodococcus infection with fatal outcome in an immunocompetent 
patient. European Journal of Clinical Microbiology & Infectious Diseases 
25(1), 46-48. 
 
Giguere S, Hondalus MK, Yager JA, Darrah P, Mosser DM, Prescott JF (1999). Role 
of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein 
A in intracellular survival and virulence of Rhodococcus. Infection and 
Immunity 67(7), 3548-3557. 
 
Goodfellow M. (1989). Genus Rhodococcus. Baltimore, Williams and Wilkins. 2362-
2371 p. 
 
Goodfellow M, Alderson G (1977). The actinomycete-genus Rhodococcus: a home 
for the "rhodochrous" complex. J Gen Microbiol 100, 99-122. 
 
Heidmann P, Madiga J, Watson J (2006). Rhodococcus Pneumonia: Clinical 
Findings, Diagnosis, Treatment and Prevention. Clinical Techniques in 
Equine Practice: 203-209. 
 
Heuzenroeder M, Barton M, Vanniasinkam T, Phumoonna T (2005). Further 
Development of vaccines against Rhodococcus infections in foals. Rural 
Industries Research and Development Corporation. 
Hondalus MKaM, David M. (1994). Survival and Replication of Rhodococcus in 
Macrophages. Infection and Immunity 62, 4167-4175. 
 
Jacks S, Giguere S, Crawford PC, Castleman WL (2007). Experimental infection of 
neonatal foals with Rhodococcus triggers adult-like gamma interferon 
induction. Clinical and Vaccine Immunology 14(6), 669-677. 
69 
 
 
Jacks Sea (2003). In Vitro Susceptiblities of Rhodococcus and other Common Equine 
Pathogens to Azithromycin, Clarithromycin, and 20 Other Antimicrobials. 
Antimicrobial Agents and Chemotherapy 47, 1742-1745. 
 
Jain S (2003). Deletion of vapA encoding Virulence Associated Protein A attenuates 
the intracellular actinomycete Rhodococcus. The Veterinary Journal 50, 115-
128. 
 
Kedlaya I, Ing MB, Wong SS (2001). Rhodococcus infections in immunocompetent 
hosts: Case report and review. Clinical Infectious Diseases 32(3), E39-E46. 
 
Kelly BG, Wall DM, Boland CA, Meijer WG (2002). Isocitrate lyase of the 
facultative intracellular pathogen Rhodococcus. Microbiology-Sgm 148, 793-
798. 
 
Ladron N, Fernandez M, Aguero J, Zorn BG, Vazquez-Boland JA, Navas J (2003). 
Rapid identification of Rhodococcus by a PCR assay targeting the choE gene. 
Journal of Clinical Microbiology 41(7), 3241-3245. 
 
Larkin MJ, Kulakov LA, Allen CCR (2005). Biodegradation and Rhodococcus - 
masters of catabolic versatility. Current Opinion in Biotechnology 16(3), 282-
290. 
 
Lavoie JP, Fiset L, Laverty S 1994. Review of 40 Cases of Lung Abscesses in Foals 
and Adult Horses. Equine Veterinary Journal 26(5), 348-352. 
 
Letek M, Ocampo-Sosa A, SAnders M, Fogarty U, Buckley T, Leadon D, Gonzalez 
P, Scortti M, Meijer W (2008). Evolution of the Rhodococcus vap 
Pathogenicity Island Seen through Comparison of Host-Associated vapA and 
vapB Virulence Plasmids. Journal of Bacteriology 190, 5797–5805. 
 
Linder R, Bernheimer AW (1997). Oxidation of macrophage membrane cholesterol 
by intracellular Rhodococcus. Veterinary Microbiology 56(3-4), 269-276. 
 
Lopez AM, Hines MT, Palmer GH, Alperin DC, Hines SA (2002). Identification of 
pulmonary T-lymphocyte and serum antibody isotype responses associated 
with protection against Rhodococcus. Clinical and Diagnostic Laboratory 
Immunology 9(6), 1270-1276. 
 
Luhrmann A, Mauder N, Sydor T, Fernandez-Mora E, Schulze-Luehrmann J, Takai 
S, Haas A (2004). Necrotic death of Rhodococcus-infected macrophages is 
regulated by virulence-associated plasmids. Infection and Immunity 72(2), 
853-862. 
 
70 
 
Magnusson H (1923). Corynebacterium equi: spezifische infektioese Pneumonie 
beim Fohlen: ein neuer Eiterreger beim Pferd. Arch Wiss Prakt Teirheilkd 50, 
22-37. 
 
Martens R, Fiske R, Renshaw H (1982). Experimental subacute foal pneumonia 
induced by aerosol administration of Corynebacterium equi. Equine 
Veterinary Journal 14, 111-116. 
 
Meijer WG, Prescott JF (2004). Rhodococcus. Veterinary Research 35(4), 383-396. 
 
Monego F, Maboni F, Krewer C, Vargas A, Costa M, Loreto E (2009). Molecular 
Characterization of Rhodococcus from Horse-Breeding Farms by Means of 
Multiplex PCR for the vap Gene Family. Current Microbiology 58(4), 399-
403. 
 
Monique I, Andersson, Alasdair P, MacGowan (2003). Development of the 
Quinolones. Journal of Antimicrobial Chemotherapy 51, 1-11. 
 
Muscatello G, Browning GF (2004). Identification and differentiation of avirulent 
and virulent Rhodococcus using selective media and colony blotting DNA 
hybridization to determine their concentrations in the environment. Veterinary 
Microbiology 100(1-2), 121-127. 
 
Muscatello G, Gilkerson J, Browning G (2006a). Rattles in Horses: Effects of stud 
management on ecology of virulent Rhodococcus. Rural Industries Reasearch 
and Deelopment Corporation. 
 
Muscatello G, Anderson GA, Gilkerson JR, Browning GF (2006b). Associations 
between the ecology of virulent Rhodococcus and the epidemiology of R-equi 
pneumonia on Australian thoroughbred farms. Applied and Environmental 
Microbiology 72(9), 6152-6160. 
 
Muscatello G (2006). Comparison of two selective media for the recovery, isolation 
and enumeration and differntiation of Rhodococcus. Veterinary Microbiology 
119, 324-329. 
 
Muscatello G (2009). Detection of Virulent Rhodococcus in Exhaled Air Samples 
from Naturally Infected Foals. Journal of Clinical Microbiology 47, 734–737. 
Navas J, Gonzalez-Zorn B, Ladron N, Garrido P, Vazquez-Boland JA (2001). 
Identification and mutagenesis by allelic exchange of choE, encoding a 
cholesterol oxidase from the intracellular pathogen Rhodococcus. Journal of 
Bacteriology 183(16), 4796-4805. 
 
Nerren JR, Payne S, Halbert ND, Martens RJ, Cohen ND (2009a). Cytokine 
expression by neutrophils of adult horses stimulated with virulent and 
71 
 
avirulent Rhodococcus in vitro. Veterinary Immunology and 
Immunopathology 127(1-2), 135-143. 
 
Nerren JR, Martens RJ, Payne S, Murrell J, Butler JL, Cohen ND (2009b). Age-
related changes in cytokine expression by neutrophils of foals stimulated with 
virulent Rhodococcus in vitro. Veterinary Immunology and Immunopathology 
127(3-4), 212-219. 
 
Ocampo-Sosa AA, Lewis DA, Navas J, Quigley F, Callejo R, Scortti M, Leadon DP, 
Fogarty U, Vazquez-Boland JA (2007). Molecular epidemiology of 
Rhodococcus based on traA, vapA, and vapB virulence plasmid markers. 
Journal of Infectious Diseases 196(5), 763-769. 
 
Pei Y, Parreira v, Nicholson VM, Prescott J 2006. Mutation and virulence assessment 
of chromosomal genes of Rhodococcus 103. The Canadian Journal of 
veterinary Research 71, 1-7. 
 
Prescott J, Lastra M, Barksdale L (1982). Equi factors in the identification of 
Corynebacterium equi Magnusson. Journal of Clinical Microbiology 16(5), 
988-990. 
 
Prescott JF (1991). Rhodococcus equi - An Animal and Human Pathogen. Clinical 
Microbiology Reviews 4(1), 20-34. 
 
Prescott JF, Wilcock BP, Carman PS, Hoffman AM (1991). Sporadice, Severe 
Bronchointerstitial Pneumonia of Foals. Canadian Veterinary Journal-Revue 
Veterinaire Canadienne 32(7), 421-425. 
 
Ren JaP, John F. (2004). The effect of mutation on Rhodococcus virulence 
            plasmid gene expression and mouse virulence. Veterinary Microbiology 103, 
219-230. 
 
Ribeiro MG (2005). Molecular epidemiology of virulent Rhodococcus 
            equi from foals in Brazil: virulence plasmids of 85-kb type I, 87-kb type I, and 
a new variant, 87-kb type III. Comparative Immunology, Microbiology and 
Infectious Diseases 28, 53-61. 
Rodriguez-Lazaro D, Lewis DA, Ocampo-Sosa AA, Fogarty U, Makrai L, Navas J, 
Scortti M, Hernandez M, Vazquez-Boland JA (2006). Internally controlled 
real-time PCR method for quantitative species-specific detection and vapA 
genotyping of Rhodococcus. Applied and Environmental Microbiology 72(6), 
4256-4263. 
 
Russell DA, Byrne GA, O'Connell EP, Boland CA, Meijer WG (2004). The LysR-
type transcriptional regulator VirR is required for expression of the virulence 
72 
 
gene vapA of Rhodococcus ATCC 33701. Journal of Bacteriology 186(17), 
5576-5584. 
 
Sanger Institute (2008). The sequence data were produced by the Rhodococcus 
Sequencing Group at the Sanger Institute. 
 
Schleef M. (2001). Plasmids for Therapy and Vaccination. Weinheim, Wiley-VCH 
Verlag Gmbh. 259 p. 
 
Sellon D, Besser T, Vivrette S, McConnico R (2001). Comparison of nucleic acid 
amplification, serology, and microbiologic culture for diagnosis of 
Rhodococcus pneumonia in foals. Journal of Clinical Microbiology 39(4), 
1289-1293. 
 
Singer MEV, Finnerty WR (1988). Construction of An Escherichia coli Rhodococcus 
Shuttle Vector and Plasmid Transformation in Rhodococcus Spp. Journal of 
Bacteriology 170(2), 638-645. 
 
Soedarmanto I, Zhicai W, Setyamahanani A, Lammler C (1998). Pheno- and 
genotyping of Rhodococcus isolated from faeces of healthy horses and cattle. 
Research in Veterinary Science 64(3), 181-185. 
 
Sydor T, vonBargen K, Becken U, Spuerck S, Nicholson VM, Prescott J, Haas A 
(2008). A mycolyl transferase mutant of Rhodococcus lacking capsule 
integrity is fully virulent. Veterinary Microbiology 128, 327-341. 
 
Takai S (1997). Epidemiology of Rhodococcus infections: A review. Veterinary 
Microbiology 56, 167-176. 
 
Takai S, Hines SA, Sekizaki T, Nicholson VM, Alperin DC, Osaki M (2000). DNA 
sequence and Comparison of Virulence Plasmids from Rhodococcus ATCC 
33701 and 103. Infection and Immuntiy 68, 6840-6847. 
 
Takai S, Murata N, Kudo R, Narematsu N, Kakuda T, Sasaki Y, Tsubaki S (2001b). 
Two new variants of the Rhodococcus virulence plasmid, 90 kb type III and 
type IV, recovered from a foal in Japan. Veterinary Microbiology 82, 373-
381. 
 
Takai S, Watanabe Y, Ikeda T, Ozawa T, Matsukura S, Tamada Y, Tsubaki S, 
Sekizaki T (1993). Virulence-Associated Plasmids in Rhodococcus equi. 
Journal of Clinical Microbiology 31(7), 1726-1729. 
 
Takai S, Chaffin MK, Cohen ND, Hara M, Nakamura M, Kakuda T, Sasaki Y, 
Tsubaki S, Martens RJ (2001). Prevalence of virulent Rhodococcus in soil 
from five R. equi-endemic horse-breeding farms and restriction fragment 
73 
 
length polymorphisms of virulence plasmids in isolates from soil and infected 
foals in Texas. Journal of veterinary diagnostic investigation 13: 489-494  
 
Takai S, Son W, Lee D, Madarame H, Seki I, Yamatoda N, Kimura A, Kakuda T, 
Tsubaki S, Lim Y (2003). Rhodococcus Virulence Plasmids Recovered from 
Horses and Their Environment in Jeju, Korea: 90-kb Type II and a New 
Variant, 90-kb Type V. Journal of Veterinary Medicine 65, 1313-1317. 
 
Takai S, Morishita T, Nishio Y, Sasaki Y, Tsubaki S, Higuchi T, Hagiwara S, Senba 
H, Kato M, Seno N and others (1994). Evaluation of a Monoclonal Antibody-
Based Colony Blot Test for Rapid Identification of Virulent Rhodococcus 
equi. Journal of Veterinary Medical Science 56(4), 681-684. 
 
Takai S (1991a). Identification of 15- to 17-Kilodalton Antigens Associated with 
            Virulent Rhodococcus. Journal of Clinical Microbiology 29, 439-443. 
 
Takai S (1991b). Association between a large plasmid and 15- to 17-kilodalton 
antigens in virulent Rhodococcus. . Infection and Immunity 59, 4056-4060. 
 
Takai S (1995). Identification of virulent Rhodococcus by amplification of gene 
coding for 15- to 17-kilodalton antigens. Journal of Clinical Microbiology 33, 
1624-1627. 
 
Takai S (1999). Restriction Fragment Length Polymorphisms of Virulence Plasmids 
in Rhodococcus. Journal of Clinical Microbiology 37, 3417-3420. 
 
Tan C, Prescott JF, Patterson MC, Nicholson VM (1995). Molecular Characterisation 
of a lipd-modified Virulence-Associated Protein of Rhodococcus equi and its 
Potential in Protective Immunity. Canadian Journal of Veterinary Research-
Revue Canadienne De Recherche Veterinaire 59(1), 51-59. 
 
Tkachuksaad O, Prescott J (1991). Rhodococcus equi Plasmids -Isolation and Partial 
Charaterisation. Journal of Clinical Microbiology 29(12), 2696-2700. 
Vazquez-Boland JA, Prescott JF, Meijer WG, Leadon DP, Hines SA (2009). 
Rhodococcus comes of age. Equine Veterinary Journal 41(1), 93-95. 
 
Venner M, Meyer-Hamme B, Verspohl J, Hatori F, Shimizu N (2007). Genotypic 
characterization of VapA positive Rhodococcus in foals with pulmonary 
affection and their soil environment on a warmblood horse breeding farm in 
Germany. Research in Veterinary Science 83, 311-317. 
 
 
 
 
74 
 
Venner M (2007). Efficacy of azithromycin in preventing pulmonary abscesses in 
foals. The Veterinary Journal 79, 301-303. 
 
von Bargen K, Haas A (2009). Molecular and infection biology of the horse pathogen 
Rhodococcus. Fems Microbiology Reviews 33(5), 870-891. 
 
Walker J (1984). Methods in Molecular Biology. Walker J ed. Clifton, The Humaria 
Press Inc. 
 
Wall DM, Duffy PS, DuPont C, Prescott JF, Meijer WG (2005). Isocitrate lyase 
activity is required for virulence of the intracellular pathogen Rhodococcus. 
Infection and Immunity 73(10), 6736-6741. 
 
Walsh T, Standiford H, Reboli A, John J, Mulligan M, Ribner B, Montgomerie J, 
Goetz M, Mayhall C, Rimland D (1983). Randomized double-blinded trial of 
rifampin with either novobiocin or trimethoprim-sulfamethoxazole against 
methicillin-resistant Staphylococcus aureus colonization: prevention of 
antimicrobial resistance and effect of host factors on outcome. . American 
Society for Microbiology 37, 1334-1342. 
 
Warhurst AM, Fewson CA (1994). Biotransformations Catalyzed by the Genus 
Rhodococcus. Critical Reviews in Biotechnology 14(1), 29-73. 
 
Wichtel MG, Anderson KL, Johnson TV, Nathan U, Smith L (1991). Influence of age 
on Neutrophil function in Foals. Equine Veterinary Journal 23(6): 466-469. 
 
Williams LE, Detter C, Barry K, Lapidus A, Summers AO (2006). Facile recovery of 
individual high-molecular-weight, low-copy-number natural plasmids for 
genomic sequencing. Applied and Environmental Microbiology 72(7), 4899-
4906. 
 
Woolcock J, Farmer A, Mutimer M (1979). Selective Medium for Corynebacterium 
equi isolation. Journal of Clinical Microbiology 9(5), 640-642. 
 
Yager JA, Prescott CA, Kramar DP, Hannah H, Balson GA, Croy BA (1991). The 
Effect of Experimental-Infection with Rhodococcus equi on Immunodeficient 
mice. Veterinary Microbiology 28(4), 363-376. 
 
Yang X, Liu X, Song L, Xie F, Zhang G, Qian S (2007). Characterization and 
functional analysis of a novel gene cluster involved in biphenyl degradation in 
Rhodococcus sp strain R04. Journal of Applied Microbiology 103(6), 2214-
2224. 
 
 
 
75 
 
5 Appendix 
5.1 Appendix: Additional Protocols 
5.1.1 Media 
       Making NANAT selective media to isolate R. equi 
1. To make 400 mL of the selective media, 6g of agar and 14.8g of BHI were 
added to 400 mL of H2O.  
2. After autoclaving the media and cooling it to 50ºC, 1 mL of Polymyxin B 
(10mg/mL), 1 mL of Naladixic Acid (10mg/ml), 1 mL of Novobiocin 
(10mg/ml) and 2 mL of Cyclohexamide (10mg/mL) were added and the 
media was mixed by inverting it ten times. 
3. Approximately 15 mL of the media was poured into each of the pentri dishes 
which were cooled overnight and then refrigerated for future use.  
  
Making BHI (Blood Heart Infusion) agar to grow R. equi  
1. 7.5g of Agar and 18.5g of BHI was added to 500 mL of distilled water.  
2. The medium was autoclaved in a pressure cooker for 20 -40 min, cooled in a 
water bath at 50ºC for about 30 min and then approximately 15 mL was 
poured into each pentri dish after which they were cooled overnight.  
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Storage of nasal swabs and broth containing positive bacteria samples 
1. Nasal swabs were stored in a -80 ºC refrigerator. 
2. BHI broth was made in the above mentioned way excluding the addition of 
agar, 10 mL of broth was poured into 15 mL universals. 
3. Broth was inoculated with a loop full of virulent positive bacteria and grown 
in a shaking incubator at a speed of 200 rpm at 30-37 ºC for 24 or 48 h. 
4. 1 mL of Sterile Glycerol was added to each of the universals, they were 
inverted a few times and approximately 1 mL of the broth was put into long 
storage tubes. 
5. These tubes were stored in a -80 ºC refrigerator. 
 
5.1.2 Colony Hybridization 
       
1.  Nylon Membranes (Hybond) were cut into circles roughly the same size as 
the plates.  
2. Single R. equi colonies were grown on plates overnight.  
3. The Nylon membranes were placed on the plates for about a minute and 
markings were drawn on the edges of the membrane as well as on the plates 
so that the orientation is known.  
4. Using tweezers the membranes were lifted off the plates and put on a small 
tray (Bacteria facing up) containing Lysis Solution (10 mM Tris-HCl, 1 mM 
EDTA pH 8.0, 80mg/mL lysozyme) and then heated at 80ºC for 10 min.  
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5. The membranes were put on a filter paper for a couple of minutes then were 
transferred onto another filter paper that was immersed in Denaturing Solution 
(0.5M NaOH, 1.5M NaCl) for about 3 min.  
6. The membranes were transferred twice for 3 min each onto separate trays with 
filter papers (Whatman 3MM) immersed in 3 X SSC (20 X SSC is 3M NaCl 
and 0.3M sodium citrate) Solution. 
7.  Small lids were filled with 3 X SSC just about 1cm high and with the bacteria 
facing up membranes were placed in the lids.  
8. They were put on an Orbital shaker (Bellco Glass, INC.) set at speed 3.5 for 
about 10 min. 
9.  The 3 X SSC was drained out from the lids and fresh 3 X SSC was added to 
them and again shaken on the Orbital shaker for 10 min.  
10. The membranes were then dried on filter paper at 80ºC for a couple of hours, 
the crosslinker (BLX-Z54, Life Technologies) was set at 0.120 and the 
membranes were exposed to UV light.  
11. The membranes were put into tubes and then pre-hybridised with 5 mL of 
Church and Gilbert (0.5M Na2HPO4 pH 7.2, 1% BSA, 1 mM EDTA, 7% 
SDS) for about 30 min rotating at 55ºC.  
12. The Church and Gilbert solution was drained out of the tubes and 5 mL of the 
radioactively labelled VapA probe (10 pmol) {purified VapA PCR product 
was used to construct 32P labelled probes using a Primed DNA Labelling Kit 
(Roche Diagnostics) according to the manufacturers recommendations} 
tagged with the primer was added to the tubes.  
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13. The tubes were set onto a rotator such that they were balanced and allowed to 
rotate at 55ºC overnight after which the probe was poured back into its falcon 
tube and stored in the fridge for future use.  
14. The membranes were washed twice with 3 X SSC while shaken at 37ºC for 
20-30 min each time.  
15. The membranes were dried completely by placing them on a filter paper and 
heating at 37ºC for two hours.  
16. The membranes were taped onto a filter paper and put in a cassette, a 
photographic paper was placed on the membranes in the dark room; the 
cassette was shut, wrapped in a black bag and put in a cupboard overnight.  
17. The next day, the photographic paper was developed and fixed for 90 sec. 
  
5.1.3 Staining  
   DAPI Staining 
1. About 15 µl of Milli-Q H2O was used to form a drop on a slide.  
2. The drop was emulsified with a single streak of R. equi bacteria, heat-fixed 
and dried at room temperature.  
3. The cells were fixed with 2-3 drops of cold methanol and then dried at room 
temperature.  
4. The above step was repeated three times after which the slide was washed 
with large amounts of tap water about 4-6 times and dried as before at room 
temperature.  
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5. 10 µl of poly-L-lysine (5 µg ml-1) was smeared over the fixed and washed 
cells and they were left to dry at room temperature.  
6. 10 µl of DAPI (0.2 µg ml-1 in 40% glycerol) was used to stain the cells after 
which a cover clip was placed on the slide then viewed on a microscope. 
 
Gelstar Staining 
Exactly the same procedure as for DAPI staining was followed with the exception of 
a 1/5000 dilution of Gelstar used instead of DAPI.  
Stains were used to allow better visualisation of plasmids 
Ethidium Bromide (EtBr) 
1. As opposed to adding EtBr while making the agarose gel, EtBr was used to 
stain the gel by adding it to the buffer in which it was soaked once the DNA 
had already been electrophoresed. 
2. Approximately 6 µl of EtBr (10 mg/mL) was added to 150 mL of buffer. 
SYBR Green  
1. A couple of µl of SYBR Green (10,000 X) was directly added to the DNA 
before gel electrophoresis. 
2. 2.5 µl of SYBR Green was added to 10 µl of plasmid DNA. 
The two stains were compared to see which one was more useful in plasmid DNA 
visualisation. 
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5.1.4 DNA Extraction 
PEG Lysis 
1. Single colonies were inoculated in 1.7 mL Eppendorf tubes containing 100 µl 
of 20% PEG Lysis Solution (20g PEG 8000, 14.8g NaCl/100 mL H2O) each. 
2. Tubes were heated at 95°C in an Eppendorf Thermomixer for 10 min. 
5.1.5 PCR Conditions 
1. PCR tubes were labelled for each DNA sample as well as a negative control.  
2. About 20 µl of Master Mix (MM) was required for each tube.  
3. 1 µl of primer was used per 50 µl of MM whereas 1 µl of Taq per 200 µl of 
MM was used.  
4. According to the above concentration and the number of DNA samples a mix 
of the MM, primer and Taq was made, vortexed then 20 µl of the mix was put 
into each PCR tube in the PCR cabinet.  
5. 1 to 2 µl of DNA was added to each tube depending on the achieved DNA 
concentration.  
6. A PCR (Peltier Thermal Cycler PTC-200, BIO-RAD) machine was used for 
the amplification.  
PCR Master Mix 
10mM Tris (pH8.3) 
2.5mM MgCl2 
250mM deoxynucleotide triphosphates (dNTP) 
81 
 
 
Deoxynucleotide triphosphates (dNTP) stock solution: 
dATP, dCTP, dGTP and dTTP (Eppendorf) dissolved to a final concentration of 
250µM in TE buffer. 
 
Temperature Gradient PCR 
A different annealing temperature is programmed into the thermocycler for each tube 
column across the thermocycler.  
 
5.1.6 PCR Cleanup Methods 
Purifying PCR Product for sequencing 
1. 10 µl of PCR product was put into a 1.7 mL tube.  
2. An equal volume of 20% PEG/NaCl was added to the tube.  
3. It was left on the bench for about 15 min to allow precipitation.  
4. The tube was spun in the centrifuge for 10 min at 16k.  
5. 1ml of 100% Ethanol was added to the tube; once it was mixed well by 
inverting it a few times it was spun in the centrifuge for 15 min.  
6. All the ethanol was pipetted out without disturbing the pellet.  
7. 1 mL of 70% Ethanol was added to the tube; it was inverted a few times, spun 
in the centrifuge for 10 min at 16k and again discarded while making sure the 
pellet is not disturbed.  
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8. 15 mL of sterile water was added to the tube and then the concentration of 
DNA was measured using a nanodrop.  
Reprecipitation to cleanup PCR products 
1. Add 5 µL of NaOAc and 50 µL of nuclease-free H2O to 10 µL of DNA. 
2. 2 volumes of 100% Ethanol was added to the above and precipitated on ice 
for 20-30 min. 
3. Centrifuged at 16k for 15 min. 
4. Supernatant discarded and pellet was resuspended in 7-10 µL of nuclease-free 
H2O. 
5. Nanodrop was used to check the concentration. 
 
5.1.7 DNA and PCR Quality and Quantity Indicators 
NanoDrop 
1. Place 2 µl Milli-Q H2O on the lens and close. Click OK to BLANK. 
2. Wipe lens using KimWipe tissue. 
3. Place 2 µl Milli-Q H2O/elution buffer (TE) on lens, close and click 
REBLANK. 
4. Wipe using KimWipe. 
5. Place 2 µl of the sample on lens and close. 
6. Enter sample name and click MEASURE. 
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7. After all samples have been measured click SHOW REPORT, adjust as 
necessary. 
Electrophoresis 
 1% Agarose and 1 X SB buffer for DNA under 1200bp run at about 110 V. 
 0.7% Agarose and 1 X TBE buffer for large plasmids and DNA over 1000bp 
run at about 40 V. 
 2% Agarose and 1 X TBE buffer for digested DNA under 500bp with 
multiple bands that are of similar length run at about 60 V. 
 10 µL DNA + 2 µL gel loading buffer (BPB). 
 1 µL of Ethidium Bromide (10mg/mL) stain per 10 mL of Agarose 
 UV Alpha Imager used to capture image of gel. 
1% Agarose gel:       
35 mL 1 X SB buffer 
0.35 g Agarose 
1.5 µl Ethidium Bromide solution (10mg/mL) 
0.7% Agarose gel:     
35 mL 1 X SB buffer 
0.24 g Agarose     
1.5 µl Ethidium Bromide solution (10mg/mL) 
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2% Agarose gel:       
35 mL 1X SB buffer 
0.7 g Agarose 
1.5 µl Ethidium Bromide solution (10mg/mL) 
 
10 X SB (Sodium Borate) buffer (pH 8.5) (Stock Solution 2 L):  
56 g Boric acid 
9 g NaOH 
 
1 X SB buffer:           
200 mL 10 X SB buffer 
1800 mL deionised H2O 
 
5 X TBE (Tris Borate EDTA) buffer (pH 8.0) (Stock Solution 1 L):     
54g Tris Base 
27.5g Boric Acid 
20ml 0.5 EDTA 
 
1 X TBE buffer:  
100 mL 5 X TBE 
1900 mL deionised H2O 
 
50 X TAE (Tris-acetate-EDTA) buffer (pH 8.3) (Stock Solution 1 L): 
242g Tris 
57.1 mL Acetic Acid 
100 mL 0.5 EDTA 
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1 X TAE buffer: 
20 mL 50 X TAE buffer 
980 mL deionised H2O 
 
Gel loading buffer:   
10 mL Glycerol 
 4 mL EDTA 
 2 mL 10% SDS 
 1.5 mL H2O 
 
5.1.8 Gel Extractions 
Conventional Band Stabs 
1. Run 1% Agarose gel with 1 X TAE buffer 
2. Place on UV box 
3. Cut tip of 100 µl pipette tip. 
4. Turn on UV and stab target band with pipette tip. 
5. Turn off light and remove tip from gel. 
6. Expel gel from tip into 1.7 mL Eppendorf tube. 
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DNA excision 
1. Place gel on a glass above the UV base (Safe Imager, Invitrogen), put on 
protective headgear, and the lights were switched off. 
2. Using a scalpel, razor blade or cover slip splice band in gel (Keep UV light 
turned on for a minimum amount of time to prevent DNA damage). 
3. Lift slice out of the gel and place in an 1.7 mL Eppendorf tube. 
Freeze and Squeeze method for gel band purification 
1. A hole was made at the bottom of a 0.7 mL Eppendorf tube using a sterilised 
25mm needle.  
2. A glass bead was placed inside the tube and the cut out band from the agarose 
gel was placed just on top of the glass bead in the tube. 
3.  The 0.7 mL tube was put inside a 1.5 mL Eppendorf tube and frozen at -80ºC 
for 30 min.  
4. It was then centrifuged at 16k for 15 min. For the rest of the extraction the 
same protocol as the one above from PCR product purification was followed. 
Gel Band Purification using the Illustra
TM  
Extraction Kit 
1. Following PCR to amplify the desired areas of the plasmid, bands of the PCR 
products that were run on the gel were cut out using a razor blade. 
2. These were purified using the manufacturer‟s protocol in IllustraTM GFX PCR 
DNA and gel Band Purification Kit (This was done by adding capture buffer 
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to the gel sample, incubating it at 60ºC to dissolve the agarose, transferring it 
to a GFX column placed in a collection tube and washing it with wash buffer). 
3.  They were sent out to the Waikato DNA sequencing facility to ensure 
matches of the sequences with those available from GenBank. 
Gel Band Purification using the Zymoclean
TM  
Gel DNA recovery Kit. 
1. DNA fragments from the agarose gel were removed by band stabbing and 
transferred to 1.5 mL Eppendorf tube. 
2. 3 volumes of ADB BufferTM was added to each volume of agarose excised 
from the gel. 
3. Samples were incubated at 55 ºC for 5-10 min until the gel slices were 
completely dissolved. 
4. The melted agarose solution was transferred to a Zymo-Spin I TM Column in a 
Collection tube. 
5. They were centrifuged at 10,000 rpm for 45 sec and the flow-through was 
discarded 
6. 200 µl of Wash buffer was added to the column and centrifuged at 10,000 rpm 
for 45 sec, flow-through was discarded and this wash step was repeated. 
7. 10 µl of Milli-Q  H2O was added directly to the column matrix  
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8. Columns were placed into 1.5 mL tubes and centrifuged again at 10,000 rpm 
for 45 sec to elute DNA. 
 
5.1.9 Plasmid Isolations/Purifications 
 Plasmid Isolation Method A 
1. A few µL of broth stored at -80ºC was streaked onto plates and colonies grew 
overnight.  
2. Loops full of bacteria were transferred to 10 mL of BHI broth which were 
grown overnight at 37ºC in a shaking incubator.  
3. Bacteria were transferred to 1.7 mL Eppendorf tubes, spun down in a 
centrifuge at 16k for 30 sec and then the pellets were resuspended in 50 µl of 
TE.  
4. 300 µl of TENS Buffer (0.1M NaOH, 0.2% SDS, 1mM EDTA, 10mM Tris 
pH 7.5) was added to the tubes and were put in 80ºC for 5 min. 150 µl of 3M 
NaOAc was added to the tubes; they were vortexed and spun for 2 min at  
16k.  
5. Using a flat ended toothpick the pellets were removed and discarded. 300 µl 
of Phenol: Chloroform was added to each tube, after vortexing the tubes they 
were centrifuged at 16k for 5 min.  
6. The supernatant was removed and transferred to separate fresh tubes. 
Approximately equal amounts of 100% isopropanol was put into each tube 
and left on the bench for 5 min.  
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7. After spinning them down in the centrifuge for 10 min, pellets were washed 
with 1 mL of 70% Ethanol.  
8. Once all the ethanol was discarded and pellets were air-dried for about 10 min 
depending on the size of the pellets TE was added and the concentration of 
DNA was measured using a NanoDrop. 
 
Plasmid Isolation Method B 
This variation involved using colonies grown at 37ºC on plates rather than broth and 
the use of CTAB. 
 
Plasmid Isolation Method C (Ocampo-Sosa et al. 2007) 
1. Bacteria were grown at 30ºC overnight using Brain Heart Infusion (BHI) 
broth.  
2. They were harvested by centrifugation at 16k for 10 min at 4ºC followed by 
washing with 1 X TBE and then their transfer to 1.7 mL Eppendorf tubes.  
3. After transfer they were centrifuged again under the same conditions.  
4. The pellets were resuspended in 200 µl of SETL solution (15% Sucrose, 
0.01M EDTA, 25mmol/L Tris-HCl (pH 8.0), 5mg/ml Lysozyme) and 
incubated for about 2.5 h at 37ºC.  
5. 400 µl of Lysis Solution was added then tubes were inverted 250 times until a 
homogenous viscous suspension was obtained.  
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6. 300 µl of 5 M prechilled potassium acetate  (60ml 5M KOAc, 11.5ml Glacial 
Acetic Acid, 28.5ml dd H2O) was added after which tubes were inverted again 
about a 100 times and then left on ice for 30 min.  
7. The tubes were centrifuged for 10 min at 4ºC, the supernatants were 
transferred to fresh 1.7 mL tubes and 10 µl of a 10mg/mL solution of RNase 
{896.7µl dd H2O, 3.3µl 3M NaOAc (pH 5.2), 100µl 1M Tris-Cl (pH 7.4)} 
was added.  
8. 500 µl of phenol: chloroform: isoamyl alcohol was added after incubation at 
37ºC for 30 min.  
9. The tubes were gently inverted about a 100 times and then centrifuged under 
the same conditions.  
10. The supernatant was carefully discarded and the plasmid DNA was washed 
twice with 1 mL of 70% Ethanol.  
11. The pellet was air-dried for 15 min and resuspended in appropriate amounts of 
TE. 
 
Plasmid Isolation Method D (Birnboim & Doly 1988) 
1. 5 mL of bacterial colonies were grown in BHI broth for 2 days.  
2. 1 mL of cells were centrifuged at 16k for 10 min and then resuspended in 
200µl of Solution I (0.05M Tris-HCl pH 8.0, 0.01M EDTA pH 8.0, 0.5M 
NaCl, 20%Sucrose, 5mg/ml Lysozyme).  
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3. These cells were incubated at 37ºC for 2.5 h after which 400 µl of Solution II 
(2% SDS, 0.3M NaOH) was added to the tubes.  
4. The tubes were put on ice for 60 min followed by centrifugation for 5 min.  
5. The supernatant was transferred to fresh tubes. 2 µl of RNase was added to 
each tube and the incubated at 37ºC for 30 min.  
6. 500 µl of phenol: chloroform: isoamyl alcohol was added after which the 
tubes were inverted a few times then centrifuged at 4ºC for 10 min.  
7. The supernatant was added to fresh tubes and roughly equal amounts of 
Isopropanol were added to them.  
8. After centrifugation at 4ºC for 10 min the supernatant was discarded, the 
DNA was washed with 1 mL of 70% Ethanol and once all the ethanol was 
discarded and air-dried for 15 min, the pellets were resuspended in TE.  
 
Tracey‟s plasmid purification method 
1. A 1.2% agarose gel in a 0.7 mL Eppendorf tube containing a hole was placed 
over a 0.7 mL tube to collect all the purified plasmid.  
2. 10 µl of the isolated plasmid solution was put in the tube just above the 
agarose and kept overnight to allow plasmid to seep through slowly followed 
by 10 µl of TE. 
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5.1.10 Restriction Digestion of Plasmid 
           NcoI 
1. 5 µl of DNA (0.2-1 µg/µl), 2 µl of NcoI (2-10U), 2 µl of Restriction enzyme 
10X buffer 3 and 11 µl of Milli-Q H20 was added to a 1.7 mL tube. 
2. The contents were mixed gently by pipetting and then centrifuged briefly at 
12,000 x g in a micro centrifuge. 
3. The tube was incubated at 37ºC in a thermomixer for approximately 4 h, a 
restriction digestion with overnight incubation was also carried out. 
 
EcoRI 
The same protocol as above was followed except for the replacement of the 
restriction enzyme and the buffer. 
 
5.1.11 Multiple primer Analysis 
 
1. Primer DR REP IR was used in combination with other primers in an 
extended PCR to amplify regions of VP positive plasmid isolate 2.3. 
2. PCR conditions were 94ºC for 2 min, one cycle of 53.5 ºC for 20 s, 45 ºC for 
30 s, 68 ºC for 2 min, 39 cycles of 94 ºC for 20 s, 45 ºC for 30 s, 68 ºC for 2 
min and a final step at 68 ºC for 5 min. 
3. A gradient PCR was performed after which 2 annealing temperatures were 
selected. 
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5.2 Appendix: Additional Results and Discussions 
 
5.2.1 Colony Hybridisation 
 In order to find an easier way of deciphering the incidence of virulent colonies 
amongst a large number of single colonies grown on plates, radioactive labelling of 
genomic DNA with a VapA probe was attempted. The results showed that the VapA 
probe had bound to all the VP (virulence plasmid) positive colonies that were 
swabbed on an agar plate by a single VP positive colony whereas VP negative 
isolates did not bind to the VapA probe. Thus the VapA test for VP positivity was an 
efficient one. 
5.2.2 Staining with DAPI and Gelstar to identify VP positive isolates 
 DAPI (4', 6-diamidino-2-phenylindole) is known to form fluorescent complexes with 
double stranded DNA.  It was tested to see if it would bind to circular double 
stranded plasmids from VP positive isolates differently and be able to show a visual 
difference between VP positive and VP negative R. equi samples based on 
fluorescence. A number of dilutions of R. equi positive and R. equi negative bacteria 
were stained with DAPI but no significant differences were found in the staining of 
either of the bacteria on observation under a microscope. All the bacteria were stained 
blue under UV light. 
5.2.3 PCR Optimization 
In order to increase specificity of PCR a temperature gradient was trialled to 
determine the optimal PCR temperature as well as the adjustment of template DNA 
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concentrations. Negative and positive controls were used for all trials. The negative 
control consisted of Milli-Q H2O in the place of DNA where as the positive control 
used sample DNA known to amplify well. 
5.2.4 Temperature Optimization 
The choice of annealing temperatures in PCR is related to the concentration of the 
DNA template. If the concentration of the template DNA is low then the annealing 
temperature should be low. If the temperature is increased there will be a lot of 
unspecific binding. When primer length is increased so should the annealing 
temperature to get higher specificity for the PCR reaction. Thus the annealing 
temperature was increased by 5 ºC from 55 ºC to 60 ºC when the TraA primer was 
used to amplify a product size of 959-bp in comparison to when the VapA primer was 
used at 55 ºC to amplify a product size of 286-bp. Performing a temperature gradient, 
as has been done for the multiple primer analysis, assisted in choosing the right 
annealing temperature for amplifying the specific sequences. 
5.2.5 Post-PCR DNA Processing 
Some samples contained multiple PCR products of different sizes due to non-specific 
binding, which prevented direct sequencing. When this occurred, the PCR products of 
desired sizes had to be excised from the electrophoresis gel. The annealing 
temperature could be adjusted to obtain single products but even when single desired 
products were obtained in an electrophoresis gel and the remaining PCR products 
were purified the sequencing data showed the presence of a smaller product. This 
suggested that since there was a small quantity of the undesired product it was not 
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visible in the electrophoresis gel. It was better to band stab the desired products for all 
samples from an electrophoresis gel whether there was non-specific binding or not in 
order to prevent any contamination with undesired products. Gel band extractions 
performed by the ZymocleanTM
  
Gel DNA recovery Kit seemed to present better 
quality  sequences in comparison to using the freeze and squeeze method and the 
Illustra
TM  
Extraction Kit. 
5.2.6 Plasmid Isolations 
Before carrying out any plasmid isolation method it was ensured that the bacteria 
were tested for the presence of plasmid by the VapA or TraA tests due to its ability to 
be lost during growth in media (von Bargen & Haas 2009). A number of different 
methods were used in an attempt to isolate plasmids from bacterial samples and a 
number of difficulties were faced while doing so. Isolations with Method A showed 
very less or no plasmid DNA and a smear of chromosomal DNA was generated at 
50,000-bp as seen in figure. It was alleged that method A needed to be modified in 
order to yield better quality and more quantity of plasmid. Since R. equi bacteria have 
a thick polysaccharide capsule which is known to be a hindrance when isolating 
plasmids (Prescott 1991) it was thought that perhaps in Method A the cells were not 
being lysed therefore, in one of the later steps, CTAB was added to the bacteria as it 
would dissolve any polysaccharide that may not have dissolved in earlier steps and 
allow cell lysis. Bacteria used for isolations in Method A were taken from broth thus 
in order to see if growth media might have been involved in making cells more 
susceptible to plasmid isolations, plasmids were isolated from bacteria grown on both 
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broth and agar plates. The modification made to Method A was Method B, which 
used bacteria grown on agar plates instead of broth and involved the addition of 
CTAB. Neither the CTAB nor the growth media seemed to improve the plasmid 
isolations even when repeated a number of times however more chromosomal DNA 
was generated as seen in figure. The next method tested was Method C, which has 
been quite frequently used since the 90s, and was followed exactly from a published 
paper (Ocampo-Sosa et al. 2007) but repeated attempts did not yield any positive 
results. Another method, Method D obtained from a paper by Birnboim and Dolly 
(Birnboim & Doly 1988) was tested and just as before repeated attempts failed to 
show plasmid DNA. The SDS and NaOH used in Method C and D were known to 
break the membrane‟s phospholipid bilayer and denature proteins involved in 
maintaining the structure of the cell membrane. It seemed that although the cells were 
being lysed and DNA was being released, at some point the DNA was getting lost. 
The last method tested and also the most successful was Method E which was long 
drawn out which involved using TENs Buffer and the addition of an extra 
precipitation step earlier on in the isolation procedure where 20% PEG or 100% 
Isopropanol was used. Comparisons of the two proved 20% PEG to be a better 
candidate for the extra precipitation step as it successfully showed the possible 
plasmid DNA band as shown in figure. Repeated attempts of Plasmid isolations with 
Method E yielded far too much chromosomal DNA and none if little plasmid DNA as 
shown in figure. It was possible that the chromosomal DNA band was large enough 
to be able to obscure the presence of any plasmid DNA. λDNA, which is 48,512-bp 
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in size, was used as a control for indication of chromosomal DNA in the 
electrophoresis gel. 
5.2.7 Plasmid Visualisation in electrophoresis gels 
After plasmids were isolated, success of the isolation was confirmed by PCR with the 
VapA or TraA primers to ensure the presence of plasmids. Having had success in 
VapA/TraA amplification in isolated plasmid samples, it was necessary to visualise 
plasmids on an electrophoresis gel so that bands could be excised and sequenced for 
characterisation. Due to the lack of visibility of plasmid bands in electrophoresis gels; 
buffers, agarose concentrations, voltages and running times were investigated. As the 
size of the plasmid increases its resolution in an agarose gel electrophoresis decreases 
(Schleef 2001). Thus to improve the resolution of the plasmid, electrophoresis had to 
be carried out at a low voltage, for a long time period (approximately 10 h) and a low 
concentration of agarose (0.7%). UV irradiation can create single strand breaks in 
supercoiled DNA molecules which results in monomers and dimers (Schleef 2001). 
The increasing size of plasmid makes resolution between monomers and dimers 
insufficient thus exposure to UV was minimized.  The supercoiled DNA migrates the 
fastest in the gel due to its tight conformation followed by nicked DNA and then its 
linear form (Schleef 2001). In Figure 5.1 electrophoresis has been carried out for 6h 
but for 10 h in Figure 5.2, where it was observed that the supercoiled plasmid is 
further than the linear or nicked DNA. At higher DNA concentrations the 
fluorescence intensity can reach a saturation level whereas at lower DNA 
concentrations no band is detected (Schleef 2001) thus monitoring DNA 
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concentration is also an important factor in resolution. In conclusion, gel staining of 
large plasmids generally requires a lot of experience and perseverance (Schleef 
2001).  
 
Figure 5.1: Electrophoresis gel at 6 h of running at 40V. 
 
Figure 5.2: Electrophoresis gel at 10 h of running at 40V. 
99 
 
 Electrophoresis gel figures at 6 h and 10 h using Methods A, B, C, D and E. The 
numbers are the isolates used for plasmid isolation.  
The successful Method E was repeated again for five other plasmid positive strains 
but failed to reveal the expected results that were obtained earlier. Since the gels were 
being electrophoresed for long periods of time, the possibility that EtBr used for 
staining the DNA was obscuring the results by affecting the visibility of plasmids and 
changing its topology was considered and the plasmid isolation with method E was 
repeated but instead of adding EtBr to the gel before electrophoresis it was added to 
the buffer the gel was soaked in for 20 min after electrophoresis. As observed in the 
figure below the chromosomal DNA band was less bright which was achieved by 
reducing the time of EtBr exposure. However, plasmid visibility was not significantly 
improved and out of the 5 Virulence Positive (VP) isolates tested, three failed to 
show even a faint presence of the plasmid. SYBR green was used to stain plasmid 
DNA to see if improved plasmid visualisation since is known to have a sensitivity of 
higher than 25 times that of EtBr and does not intercalate between DNA bases. SYBR 
green did not prove to be any more useful than EtBr in allowing better visualisation 
of plasmid DNA as seen in Figure 5.3. 
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Figure 5.3: Using SYBR green to stain plasmid DNA from 6 isolates, isolated by 
Method E. 
 
Figure 5.4: Staining five isolated plasmid samples with EtBr after electrophoresis is 
complete. 
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5.2.8 Restriction Digestion 
When the plasmid was cut with restriction enzyme EcoR1 the banding pattern was 
very faint and the lane in the gel appeared to be smeared as in Figure 5.5, this 
suggested that the plasmid product was not clean. Thus it would be pointless to use 
restriction enzyme digests of purified plasmid samples that were of poor quality and 
yield since all of them would have different levels of purity and that could obscure 
banding patterns of digests, thereby showing RFLPs in plasmids without there being 
a true difference between them.  
 
                                
Figure 5.5: Restriction digestion R. equi isolate 7.6 with EcoRI after being 
electrophoresed for 5 h at 50V. 
5.2.9 Multiple primer Analysis 
 When using a combination of primers in an extended PCR it was decided to use 
primers DR REP IR and Tra F since the reaction produced on prominent band 
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compared to the others. DR REP IR and Tra F together were used to amplify those 
regions in VP positive isolates to see if any polymorphisms occurred. To find the 
optimal PCR annealing temperature for using the 2 primers PCR reactions were 
carried out across temperature gradients. Temperature 53.5 and 43 ºC were chosen 
based on the multiple banding pattern that appears in Figure 5.6 as it would help 
recognise polymorphisms in isolates. When the two annealing temperatures were put 
to the test a vast number of banding patterns were observed as seen in Figure 5.7 with 
different band intensities as seen in figure suggesting non-specific binding. A better 
method was required for plasmid characterisation; hence variable regions were 
selected for RFLP analysis as discussed in the results and discussion of the Research 
method section. 
 
Figure 5.6: Temperature Gradient PCR. 
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            a)            b)   
Figure 5.7  PCR amplifications of plasmid isolations from four isolates with primers 
DR REP IR and TraF. Annealing temperature in a) is 53.5 ºC and annealing 
temperature in b) is 43 ºC. 
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5.3 Appendix: Gel Photos 
 
 
 
 
 
 
 
Figure 5.8: 16S confirmation of R. equi identification 
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Figure 5.9: VapA analysis of virulence plasmid identification in R. equi isolates. 
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Figure 5.10: TraA confirmation for presence of large plasmids in isolates.  
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5.4 Appendix: BLAST Analysis of PI and PII 
 
PI- 7.5 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage E value 
Max 
ident 
AM947677.1 
Rhodococcus vapA-
type virulence plasmid 
(pVAPA1037), strain 
103S 1620 1620 100% 0 100% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 1620 1620 100% 0 100% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 1620 1620 100% 0 100% 
AM947676.1 
Rhodococcus vapB-
type virulence plasmid 
(pVAPB1593), strain 
PAM1593 252 252 24% 5.00E-68 88% 
 
PI-9.6 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage E value 
Max 
ident 
AM947677.1 
Rhodococcus vapA-
type virulence plasmid 
(pVAPA1037), strain 
103S 1602 1602 100% 0 100% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 1602 1602 100% 0 100% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 1602 1602 100% 0 100% 
 
AM947676.1 
Rhodococcus vapB-
type virulence plasmid 
(pVAPB1593), strain 
PAM1593 252 252 24% 4.00E-68 88% 
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PI-14.3 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage E value 
Max 
ident 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 1430 1430 100% 0 99% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 1430 1430 100% 0 99% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 1430 1430 100% 0 99% 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 252 252 26% 4.00E-68 
         
88% 
 
       
 
PI-32.1 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage E value 
Max 
ident 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 1391 1391 100% 0 99% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 1391 1391 100% 0 99% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 1391 1391 100% 0 99% 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 252 252 27% 4.00E-68 88% 
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PI-30.1 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 1526 1526 100% 0 100% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 1526 1526 100% 0 100% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 1526 1526 100% 0 100% 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 252 252 25% 4.00E-68 88% 
 
PI-7.6 
 
Accession 
 
Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947677.1 
Rhodococcus vapA-
type virulence plasmid 
(pVAPA1037), strain 
103S 1441 1441 100% 0 99% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 1441 1441 100% 0 99% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 1441 1441 100% 0 99% 
AM947676.1 
Rhodococcus vapB-
type virulence plasmid 
(pVAPB1593), strain 
PAM1593 252 252 26% 4.00E-68 88% 
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PI-9.2 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947677.1 
Rhodococcus vapA-
type virulence plasmid 
(pVAPA1037), strain 
103S 1437 1437 100% 0 99% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 1437 1437 100% 0 99% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 1437 1437 100% 0 99% 
AM947676.1 
Rhodococcus vapB-
type virulence plasmid 
(pVAPB1593), strain 
PAM1593 252 252 26% 4.00E-68 88% 
 
PI-30.3 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947677.1 
Rhodococcus vapA-
type virulence plasmid 
(pVAPA1037), strain 
103S 1358 1358 100% 0 99% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 1358 1358 100% 0 99% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 1358 1358 100% 0 99% 
AM947676.1 
Rhodococcus vapB-
type virulence plasmid 
(pVAPB1593), strain 
PAM1593 252 252 28% 4.00E-68 88% 
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PI-30.2 
Accession  Description  
Max 
score  
Total 
score  
Query 
coverage  
E value  
Max 
ident  
AM947677.1  
Rhodococcus vapA-
type virulence plasmid 
(pVAPA1037), strain 
103S  1325  1325  100%  0  98%  
AP001204.1  
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence  1325  1325  100%  0  98%  
AF116907.2  
Rhodococcus virulence 
plasmid, complete 
sequence  1325  1325  100%  0  98%  
AM947676.1  
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593  252  252  28%  4.00E-68  88%  
 
PI-18.2 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 103S 1312 1312 100% 0 99% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 1312 1312 100% 0 99% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 1312 1312 100% 0 99% 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 252 252 29% 4.00E-68 88% 
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PI-25.3 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage E value 
Max 
ident 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 1336 1336 100% 0 98% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 1336 1336 100% 0 98% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 1336 1336 100% 0 98% 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 252 252 27% 4.00E-68 88% 
 
PI-39.1 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 1526 1526 100% 0 100% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 1526 1526 100% 0 100% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 1526 1526 100% 0 100% 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 252 252 25% 4.00E-68 88% 
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PI-14.1 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage E value 
Max 
ident 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 1430 1430 100% 0 99% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 1430 1430 100% 0 99% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 1430 1430 100% 0 99% 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 252 252 26% 4.00E-68 
         
88% 
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PII-36.3 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 394 394 30% 
8.00E-
111 88% 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 224 503 31% 1.00E-59 98% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 224 503 31% 1.00E-59 98% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 224 503 31% 1.00E-59 98% 
 
PII-31.3 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 394 394 32% 
8.00E-
111 88% 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 224 470 31% 1.00E-59 98% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 224 470 31% 1.00E-59 98% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 224 470 31% 1.00E-59 98% 
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PII-19.2 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 394 394 34% 7.00E-111 88% 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 224 400 29% 1.00E-59 98% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 224 400 29% 1.00E-59 98% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 224 400 29% 1.00E-59 98% 
 
PII-36.2 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 394 394 32% 8.00E-111 88% 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 224 442 30% 1.00E-59 98% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 224 442 30% 1.00E-59 98% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 224 442 30% 1.00E-59 98% 
 
118 
 
PII-40.1 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 394 394 31% 8.00E-111 88% 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 224 466 31% 1.00E-59 98% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 224 466 31% 1.00E-59 98% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 224 466 31% 1.00E-59 98% 
 
PII-42.1 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947676.1 
Rhodococcus vapB-
type virulence plasmid 
(pVAPB1593), strain 
PAM1593 390 390 35% 9.00E-110 90% 
AM947677.1 
Rhodococcus vapA-
type virulence plasmid 
(pVAPA1037), strain 
103S 207 465 37% 1.00E-54 100% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 207 465 37% 1.00E-54 100% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 207 465 37% 1.00E-54 100% 
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PII-40.2 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 394 394 37% 7.00E-111 88% 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 224 398 31% 9.00E-60 98% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 224 398 31% 9.00E-60 98% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 224 398 31% 9.00E-60 98% 
 
PII-42.2 
Accession Description 
Max 
score 
Total 
score 
Query 
coverage 
E value 
Max 
ident 
AM947676.1 
Rhodococcus vapB-type 
virulence plasmid 
(pVAPB1593), strain 
PAM1593 394 394 36% 7.00E-111 88% 
AM947677.1 
Rhodococcus vapA-type 
virulence plasmid 
(pVAPA1037), strain 
103S 224 494 37% 1.00E-59 98% 
AP001204.1 
Rhodococcus plasmid 
pREAT701 DNA, 
complete sequence 224 494 37% 1.00E-59 98% 
AF116907.2 
Rhodococcus virulence 
plasmid, complete 
sequence 224 494 37% 1.00E-59 98% 
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5.5 Appendix: Electropherograms: PII-40.1 
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PI-30.1 
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